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ABSTRACT 
 
Evaluation of the applicability of three commercially available biochemical test systems (API 
20 A, Rapid ID 32 A, and RapID ANA II) in the identification of Clostridium botulinum 
revealed that none of the tests could identify both group I (nonproteolytic) and group II 
(proteolytic) Clostridium botulinum. Neither were they capable of distinguishing between 
C. botulinum group I and II from their nontoxigenic counterparts. These test systems are 
therefore not suitable for the identification of C. botulinum. 
A multiplex PCR assay was developed for the simultaneous detection of Clostridium 
botulinum types A, B, E, and F in food and faecal material. The method was specific for 
C. botulinum, and was 10-fold more sensitive to C. botulinum type B than to the other 
serotypes. Following two-step enrichment the assay was very sensitive, its detection limit in 
food and faecal samples being 10-1-10-2 spore/g. Five out of 72 (7%) naturally contaminated 
food samples were positive for C. botulinum types A, B, or E. The multiplex PCR assay 
markedly improves the diagnostics of C. botulinum. 
The heat resistance of nonproteolytic C. botulinum type E spores was greater in rainbow 
trout medium than in whitefish medium. When the spores were heated in the presence of 
lysozyme, biphasic thermal destruction curves were observed in both fish media, indicating 
that 0.1% of the spore population was more heat resistant than the rest of the spores. The 
decimal reduction times (D-values) of the heat-resistant spore fraction were observed to be 
greater than those previously reported for type E spores in fish media. 
Safety evaluation of thermal processes employed in the Finnish fish and sous vide food 
industry showed that a number of vacuum-packaged hot-smoked fish products and sous vide 
products are grossly under-processed with respect to the elimination of nonproteolytic 
C. botulinum spores. As the storage temperatures at the retail and consumer level frequently 
exceed 3ºC, a great botulism hazard is associated with these products. Therefore, heat 
treatments which controlled the growth and toxin formation from 105.3-106 spores of 
nonproteolytic C. botulinum in vacuum-packaged hot-smoked fish products and in sous vide 
processed meat products stored at 4-8ºC were identified. Moist heat treatments at 85ºC for 34 
min and 42 min combined with a high relative humidity of >70% controlled C. botulinum type 
E in vacuum-packaged smoked rainbow trout and whitefish stored at 8ºC for 35 d. With sous 
vide foods, heating at 85ºC for 515 and 67 min controlled the growth and toxigenesis of 
nonproteolytic type B in pork cubes stored at 8ºC for 14 d and in ground beef stored at 4ºC for 
28 d, respectively. Heating at 85ºC for 15 min or less resulted in toxin formation in smoked 
fish and sous vide products stored at 8ºC. 
The sensory quality of all sous vide foods remained acceptable during the entire storage 
period at 8ºC. The intensified heat processes shown to control nonproteolyt ic C. botulinum 
enhanced the sensory attributes of sous vide meat products and did not markedly affect those 
of hot-smoked whitefish, but they slightly decreased those of hot-smoked rainbow trout. In 
order to control the risk presented by nonproteolytic C. botulinum in refrigerated processed 
foods of extended durability, the use of the intensified processes described in the present work 
in combination with proper refrigeration is strongly recommended for improving the safety of 
these food products. 
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1. INTRODUCTION 
 
Consumers’ demands for fresh-like high-nutrition foods and easy cooking – heat up and eat – 
has generated an entire branch of the food industry over the last decades. New packaging 
technologies ensuring extended shelf lives in combination with minimal heat processing and a 
limited use of preservatives are a prerequisite in today’s food processing. Unfortunately the 
revolutionary processing methodologies do not only promise convenience and health, but pose 
serious hazards due to dangerous micro-organisms, the most important of these being the 
spore-forming Clostridium botulinum.  
Since the first reported incidents of human botulism in the early 19th century (Kerner, 
1820), Clostridium botulinum has frightened food processors in the canning industry, 
including the numerous innocent home-canners with their tiny little leaking jars, in the 
smoked fish industry, and among various ethnic cultures with their original food preparation 
habits. As soon as the major hazards related to the canning industry were overcome by 
introducing the 12-D concept (botulinum cook), a heat process reducing the probability of 
growth from a single spore by a factor of 1012, concerns over the less heat-resistant, but 
psychrotrophic, strains of nonproteolytic C. botulinum were raised. In the 1960’s in the USA, 
large type E human botulism outbreaks due to vacuum-packaged hot-smoked fish led to 
extensive research efforts concerning the prevalence, growth, and toxin formation of 
nonproteolytic C. botulinum in fish – this work is the base for today’s scientific activities 
around botulism.  
The recognition of the great hazard presented by nonproteolytic C. botulinum in 
refrigerated processed foods of extended durability (REPFED) produced in Europe, led to 
recommendations by the Advisory Committee on the Microbiological Safety of Foods 
(ACMSF) (1992) and by the European Chilled Food Federation (ECFF) (1996) for safe 
processing and manufacturing of these foods. Analogously to the 12-D process introduced in 
the canning industry, a 6-D process was proposed. Based on large in vitro test series, several 
time temperature combinations ensuring a 106 reduction in nonproteolytic spore numbers 
were proposed, but they have since been shown to be inadequate (Fernández and Peck, 1999). 
Therefore, the importance of subjecting all new products to challenge testing by inoculated 
pack studies or predictive modelling is emphasized.  
In view of the severity of botulism and the great hazard it poses to the food industry, the 
diagnostics of C. botulinum and its toxin is still poorly developed (Robinson and Nahata, 
2003). Though rapid methods for the detection and identification of the organism in food 
laboratories would facilitate the identification of risk products, the diagnostics of C. botulinum 
is still mainly based on toxigenicity detection by the mouse bioassay. While being the only 
standard method for toxin detection available  (Nordic Committee on Food Analysis, 1991a), 
the assay, apart from being expensive and time-consuming, is a source of great ethical 
concern. In addition to conventional culturing with toxicity testing, molecular detection 
methods such as PCR have been developed. However, these protocols are only able to detect a 
single serotype of C. botulinum at a time, and their use in extensive screening surveys for the 
presence of C. botulinum spores in foods and in the environment is laborious. Therefore there 
is a great demand for more sophisticated rapid methods for the diagnostics of C. botulinum.  
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2. REVIEW OF THE LITERATURE 
 
2.1 Clostridium botulinum  and human botulism 
 
2.1.1 Classification of Clostridium botulinum 
 
As all clostridia, Clostridium botulinum is an anaerobic Gram-positive rod-shaped bacterium 
that forms resistant spores (Cato et al., 1986). The taxonomic denominator for C. botulinum is 
the production of botulinum neurotoxin (BoNT). Based on the serological properties of the 
toxin they produce, C. botulinum strains are divided into seven types A to G. Generally, 
C. botulinum strains of types A, B, E, and F are pathogenic to humans, whereas those of types 
C and D are animal pathogens. C. botulinum type G has not been associated with disease. Due 
to the great differences in the metabolic, phenotypic and genotypic properties between 
C. botulinum strains, the species is divided into four groups I to IV (Lee and Riemann, 1970b; 
Wu et al., 1972; Johnson and Francis, 1975; Smith and Sugiyama, 1988). Group I includes the 
proteolytic strains of C. botulinum types A, B, and F, while group II consists of the 
nonproteolytic strains of C. botulinum types B, E, and F. Group III includes all C. botulinum 
type C and D strains. The earlier group IV C. botulinum includes type G toxin producing 
strains, but due to the distinct phenotypic and genotypic features of the group IV organisms 
(Giménez and Ciccarelli, 1970), a species name of Clostridium argentinense has been adopted 
(Suen et al., 1988). In addition to C. botulinum, some strains of its close relatives Clostridium 
butyricum and Clostridium baratii are known to produce botulinum neurotoxin types E and F, 
respectively (Hatheway, 1993).  
 
2.1.2 Phenotypical characteristics and the microbial ecology of Clostridium 
botulinum 
 
C. botulinum is a Gram-positive, rod-shaped, anaerobic bacterium that forms heat-resistant 
spores. The phenotypic characteristics of C. botulinum strains vary greatly between groups I 
to III.  
The organisms of group I are proteolytic and capable of utilizing amino acids as an 
energy source. These strains readily ferment glucose and fructose, but their use of other sugars 
is limited (Smith and Sugiyama, 1988). As their main metabolic end products the group I 
strains produce isobutyric, isova leric, and beta-phenylpropionic acids (Smith and Sugiyama, 
1988; Hatheway, 1993). The minimum growth temperature of group I strains is 10°C (Lynt et 
al., 1982) with the optimum being 35 to 40°C (Smith and Sugiyama, 1988). Under otherwise 
optimal conditions, the ir growth is typically inhibited by a water activity (aw) of 0.94, 
corresponding to approximately 10% of NaCl (w:v) in brine. Growth may occur at pHs as low 
as 4.3 (Smelt et al., 1982) to 4.5. The spores of group I C. botulinum possess a very high heat 
resistance (Stumbo et al., 1975). Their nontoxigenic counterpart, Clostridium sporogenes, is 
phenotypically similar and genotypically related to group I C. botulinum (Lee and Riemann, 
1970a, b; Nakamura et al., 1977). 
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The strains of group II C. botulinum are nonproteolytic and saccharolytic. Basically they 
do not metabolize amino acids but ferment a number of carbohydrates as their main energy 
source (Cato et al., 1986). Their minimum growth temperature is 3.0°C (Schmidt et al., 1961; 
Eklund et al., 1967a, b; Graham et al., 1997), with the optimum being generally between 26 
and 30°C (Smith and Sugiyama, 1988; Hatheway, 1993). The inhibitory aw for group II 
organisms is typically 0.97, corresponding to 5% of NaCl in brine. Growth may occur at pH 5 
and above (Segner et al., 1966). The spores of the nonproteolytic group II organisms are less 
heat-resistant than those of group I. Nontoxigenic type E-like counterparts of nonproteolytic 
C. botulinum have been identified, with some of these strains having been reported to inhibit 
the nonproteolytic C. botulinum by producing boticins (Kautter et al., 1966; Lynt et al., 1982). 
A high genetic relatedness between the toxigenic and nontoxigenic organisms has been 
observed (Lee and Riemann, 1970a). 
Group III C. botulinum strains are mainly nonproteolytic and the ir main fermentation 
products include propionic and butyric acids (Smith and Sugiyama, 1988). These organisms 
grow generally at temperatures above 15°C, with the optimum being at approximately 40°C 
(Segner et al., 1971). The growth of group III C. botulinum is inhibited by pH of 5.1 to 5.6 
and a NaCl brine content of 2.5% (w:v). The group III organisms have an intermediate heat 
resistance as compared to those of groups I and II (Hatheway, 1993). A reversible conversion 
of group III C. botulinum to its nontoxic variant, Clostridium novyi, has been reported to 
occur as a consequence of bacteriophage transmission (Nakamura et al., 1983). 
 
2.1.3 Human botulism 
 
With a few exceptions of type F botulism, the majority of human botulism cases worldwide 
are due to types A, B, and E toxins. All forms of human botulism develop as a consequence of 
BoNT entering the blood circulation and blocking neurotransmitter release in the peripheral 
nerve endings. Therefore, independent of the form of botulism the clinical manifestation of all 
forms of botulism is similar. This typically includes a descending flaccid paralysis with 
dysphagia, a dry mouth, double vision, difficulty in swallowing, dilated pupils, dizziness, and 
muscle weakness. These are accompanied by the paralysis of the more peripheral parts of the 
body, and finally by the respiratory muscle paralysis which may lead to death. In addition, 
non-specific symptoms related to different forms of botulism may precede the actual 
paralysis.  
The classical foodborne botulism is an intoxication that follows when food containing 
botulinum neurotoxin is eaten. Therefore, the first indications of illness before the paralytic 
condition are typically gastrointestinal, mainly nausea, vomiting, and abdominal cramps. The 
typical incubation period is 18-72 h, tending to be the shorter when higher amounts of toxin 
are ingested. The treatment of foodborne botulism includes the administration of a therapeutic 
trivalent antitoxin and intensive symptomatic treatment, particularly respiratory support 
(Robinson and Nahata, 2003). As the regeneration of new nerve-endings is a prerequisite for 
recovery, the treatment period is typically weeks to months. The most common differential 
diagnoses include Guillain-Barré syndrome, chemical intoxication, stroke, or staphylococcal 
food poisoning (Centers for Disease Control, 1979; Hughes et al., 1981). The estimated case-
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fatality rate of foodborne botulism outbreaks worldwide is 20% (Hatheway, 1995). During the 
last decades, a worldwide average of 450 outbreaks of foodborne botulism with 930 cases has 
been reported annually (Hatheway, 1995). More than half of the cases (52%) were due to 
BoNT type B, whereas 34% and 12% were due to types A and E, respectively. On rare 
occasions type F toxin has been associated with human botulism (Harvey et al., 2002).  
The majority (72%) of botulism outbreaks have occurred in Poland; other countries with 
a high incidence include China, the former Soviet Union, Germany, Italy, the United States, 
France, and Yugoslavia. The geographical distribution of botulism due to different toxin types 
follows the distribution of respective spore types found in the environment (Hauschild, 1989). 
Group I C. botulinum prevails in the temperate areas including southern Europe, the United 
States, Central and South America, China and Southern Asia with the majority of outbreaks 
being associated with vegetables. Group II predominates in the colder regions of the northern 
hemisphere including northern Europe and Alaska, with meat being the main source of type B 
botulism and fish and marine mammals being the main source of type E botulism (Hauschild, 
1993). Home-prepared foods (Roblot et al., 1994; Vukovic, 2000) as well as commercial 
products (Anonymous, 1964, 1991, 1998; Townes et al., 1996; Korkeala et al., 1998) have 
been reported to serve as vehicles for human botulism. The mishandling of food products 
which might cause human botulism frequently occurs in homes (Genigeorgis, 1986). 
Unlike the classical foodborne botulism, the other forms of human botulism are 
originally infections where the toxigenesis occurs in vivo. Infectious botulism is thus mainly 
considered to be caused by strains of group I C. botulinum that have an optimum growth 
temperature close to the body temperature of 37°C, whereas the growth of group II organisms 
at the same temperatures is limited (Smith and Sugiyama, 1988). As for infant botulism 
(Pickett et al., 1976; Midura and Arnon, 1976), however, in addition to C. botulinum types A, 
B (Hatheway et al., 1981; Hatheway and McCroskey, 1987), and F (Hoffman et al., 1982), 
types E and F botulism cases due to toxigenic Clostridium butyricum (Aureli et al., 1986; 
McCroskey et al., 1986; Hatheway and McCroskey, 1987) and Clostridium baratii (Hall et 
al., 1985), respectively, have been reported. Infant botulism affects small children under 1 
year of age, and the condition typically develops as a consequence of ingesting spores of 
BoNT-producing clostridia (Arnon, 1986). As the intestinal microflora of small babies is 
poorly developed, C. botulinum spores may germinate and form a vegetative culture in the 
intestine with subsequent toxin production. Infant botulism typically starts with constipation 
that may last for several days, followed by the dis tinctive flaccid paralysis that is manifested 
by impaired feeding due to difficulties in sucking and swallowing, facial muscle paralysis, 
ptosis, and general weakness (Arnon, 1989). Infant botulism has been suggested to be a 
causative agent of sudden infant death syndrome, and is occasionally misdiagnosed as cot 
death (Nevas et al., 2002b, c). The treatment concentrates on high quality supportive care with 
special attention to the patient’s nutrition and respiratory functions (Arnon et al., 1977; 
Johnson et al., 1979). The use of antitoxin is usually not required (Arnon et al., 1979), and the 
case-fatality rate is less than 2% (Centers for Disease Control and Prevention, 1998). The only 
foodstuff that has been associated with infant botulism is honey (Aureli et al., 2002) that 
carries high numbers of C. botulinum spores (Arnon, 1992; Dodds, 1993; Nevas, 2002a). Dust 
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and other materials in the environment seem to be important sources of spores (Arnon, 1992; 
Dodds, 1993). 
Wound botulism is a rare form of botulism, although it is increasingly found among 
injecting drug abusers who use contaminated needles or impure heroin (Passaro et al., 1998; 
Athwal et al., 2000, 2001; Werner et al., 2000; Mulleague et al., 2002). Wound botulism 
develops when C. botulinum spores germinate and grow in profound wounds or abscesses that 
provide C. botulinum with anaerobic conditions. The clinical picture is similar to foodborne 
botulism with the absence of the gastrointestinal signs. The median incubation period is 7 d. 
Apart from respiratory support, the treatment of wound botulism includes surgical 
debridement, antibiotics, and the administration of antitoxin. The estimated case-fatality rate 
is 15% (Hatheway, 1995). 
The adult form of infectious botulism is rare and resembles infant botulism in its 
pathogenesis and clinical status, as a result of the colonization of the intestinal tract by BoNT-
producing clostridia (Chia et al., 1986; McCroskey and Hatheway, 1988; McCroskey et al., 
1991; Fenicia et al., 1999). People with altered intestinal flora due to for example abdominal 
surgery (Isacsohn et al., 1985; Freedman et al., 1986), prolonged antimicrobial treatment or 
gastrointestinal wounds and abscesses are usually affected (Chia et al., 1986). Since a patient 
history of the ingestion of toxic foods has typically not been found (McCroskey and 
Hatheway, 1988), the diagnosis of classical foodborne intoxication may be excluded.  
Inhalation botulism may result from aerosolization of BoNT, accidentally or 
intentionally when attempting to weaponize it. A few human cases have been reported 
(Holzer, 1962). Iatrogenic botulism with local or generalized weakness is rare and has been 
reported to develop as a consequence of therapeutic injection of BoNT (Mezaki et al., 1996; 
Bakheit et al., 1997). 
 
2.2 Botulinum neurotoxin (BoNT) 
 
2.2.1 Structure  
 
C. botulinum strains produce seven immunologically distinct BoNTs, types A to G. The 
BoNTs are synthesized as single-chain polypeptides of approximately 150 kDa. These 
polypeptides are nicked by proteases to yield an active dichain form, with the resulting heavy 
chain (100 kDa) and light chain (50 kDa) being linked to each other by a single disulphide 
bond (DasGupta and Sugiyama, 1972; Yokosawa et al., 1986; Oguma et al., 1995). Generally, 
the proteolytic organisms belonging to group I produce the proteases required to yield the 
dichain toxin form, whereas the nonproteolytic strains belonging to group II require external 
proteolytic activity, e.g. by trypsin in the gastrointestinal tract. The BoNTs are 
metalloendopeptidases containing a zinc atom associated with the light subunit (Schiavo et 
al., 1992), which possesses protease activity (Oguma et al., 1997). In culture fluids and foods, 
the toxin molecules appear as progenitor toxins, larger complexes with the single-chain 
polypeptide being accompanied by nontoxic components of various molecular masses 
(Kitamura et al., 1968; Sugii and Sakaguchi, 1975). These include the nontoxic-non-
haemagglutinin component (NTNH) and haemagglutinin components (HA) of various amino 
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acid composition and molecular mass (Oguma et al., 1997). Depending on the C. botulinum 
type, various combinations of progenitor toxins are produced. 
 
2.2.2 BoNT gene cluster 
 
The gene cluster regulating the production of BoNT by groups I and II C. botulinum is located 
in the bacterial chromosome, whereas in group III C. botulinum toxigenesis is mediated by a 
bacteriophage (Nakamura et al., 1983) and in group IV by a plasmid (Zhou et al., 1995). The 
complete nucleotide sequences of the seven distinct BoNT genes (BoNT/A to BoNT/G) have 
been published (Binz et al., 1990; Thompson et al., 1990; East et al., 1992; Poulet et al., 
1992; Whelan et al., 1992a; Whelan et al., 1992b; Elmore et al., 1995). The amino acid 
sequences of different BoNTs have regions of high similarity, particularly those associated 
with the metalloprotease activity and the disulphide bonding between the light and heavy 
subunits of the dichain toxin molecule. The BoNTs of the same serotype within a 
physiological group are identical (Henderson et al., 1997). The complete nucleotide sequences 
of the genes regulating the nontoxic components have been published (Minton, 1995; Oguma 
et al., 1997; Oguma et al., 1999). These genes form a cluster with the BoNT gene and are 
located immediately upstream of the BoNT gene (Somers and DasGupta, 1991; Hauser et al., 
1994; Henderson et al., 1996; Henderson et al., 1997). The amino acid sequences of the 
NTNH and various HA components are highly conserved and show greater overall similarity 
between different serotypes than the neurotoxin sequences (Henderson et al., 1997). The gene 
expression at the BoNT gene cluster is a consequence of complex regulatory cascades. The 
factors affecting the regulatory process are still not well understood, but at least include 
exogenous nitrogen levels (Bowers and Williams, 1963; Patterson-Curtis  et al., 1989; Malizio 
et al.,1993) that play a communicative role in bacterial signalling (Parkinson and Kofoid, 
1992).  
 
2.2.3 Mode of action 
 
BoNT is the most potent naturally occurring toxin to man (Lamanna, 1959). Generally, BoNT 
blocks neurotransmitter release in the peripheral neuromuscular junctions and causes a 
descending paralysis that may lead to death as the respiratory musculature fails. 
The role of the nontoxic components of progenitor toxin is to protect the neurotoxin 
from the acidity and proteases of environmental factors, such as foods and the stomach 
(Oguma et al., 1995). Therefore, the larger is the progenitor toxin complex, the more potent is 
the toxin. In the small intestine, the HA component is involved with the adhesion of the 
progenitor toxin to the intestinal epithelium, leading to efficient absorption of the toxin 
(Oguma et al., 1995; Fujinaga et al., 1997, 2000). Unsialylated oligosaccharides on the 
surface of the small intestine have been suggested to be the receptors for type A progenitor 
toxin, but not for the toxin itself (Inoue et al., 2001). The non-acidic conditions in the small 
intestine cause the toxin molecule to dissociate from the NTNH-HA complex and the 
nontoxic components are absorbed into the lymphatic system (Sugii et al., 1977). The single-
chain toxin molecule dissociates into the active dichain form as a result of the action of 
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proteolytic enzymes. The mechanism by which the toxin enters the lymphatic vessels is still 
unclear.  
The mechanism by which BoNT affects a nerve cell consists of four steps: cell binding, 
internalisation, membrane translocation, and target modification in the cytosol (Montecucco 
and Schiavo, 1994). The binding of BoNT to the presynaptic membrane is mediated by the C-
terminal of the heavy chain through type-specific receptors with a high affinity (Nishiki et al., 
1996). After binding, the BoNT is internalised in membrane vesicles into the nerve cell 
through an energy-dependent process (Black and Dolly, 1986). After this, the toxin can no 
longer be inactivated by a specific antitoxin. Inside the cell, the light chain of the BoNT 
molecule is transferred to the cytosol by membrane translocation. The light chain acts through 
its zinc-endopeptidase activity (Montecucco and Schiavo, 1993) and specifically cleaves the 
SNARE complex proteins (soluble NSF-attachment protein receptors [NSF, N-
ethylmaleimide-sensitive fusion protein]), such as vesicle-associated membrane protein 
(VAMP)/synaprobrevin (Schiavo et al., 1992), synaptosomal protein (SNAP-25) (Blasi et al., 
1993; Schiavo et al., 1993), and syntaxin (Schiavo et al., 1995) that are involved with 
neurotransmitter release from synaptic vesicles. This is seen as a blocked neuronal impulse 
and the paralysis of the muscle.  
 
2.3 Diagnostics of botulism 
 
The diagnosis of botulism is primarily based on the history of eating suspected foods as well 
as detecting BoNT in patients and in suspected food samples (Kautter and Solomon, 1977; 
Centers for Disease Control and Prevention, 1998; Nordic Committee on Food Analysis, 
1991a). The detection of C. botulinum cells in clinical and food specimens strongly supports 
the diagnosis (Nordic Committee on Food Analysis, 1991b). Electromyography (EMG) may 
be used to distinguish botulism from similar neurological diseases (Centers for Disease 
Control and Prevention, 1998).  
The complexity of the diagnostics is due to the fact that sensitive and specific in vitro 
methods for the detection of BoNTs have not been validated, and the only standard method is 
the mouse bioassay, which leads to ethical concern due to the use of laboratory animals. The 
culture method is complicated by the fact that no growth media selective for both proteolytic 
and nonproteolytic C. botulinum are available. Moreover, the presence of nontoxigenic 
strains, closely resembling C. botulinum, in foods and environmental samples greatly 
complicates the conventional diagnostics of the organism (Broda et al., 1998).  
 
2.3.1 Botulinum neurotoxin 
 
Mouse assay 
 
The mouse assay is the only standard method for the detection of BoNTs. Apart from toxin 
detection in clinical and food samples, the assay may be used to show toxigenesis in cultures 
providing the identification of C. botulinum strains (Kautter and Solomon, 1977). The toxin in 
a sample is eluted in a phosphate buffer and injected intraperitoneally into two mice. Trypsin 
  10 
activation of the eluate is generally required when strains from group II C. botulinum are 
concerned (Duff et al., 1956), as those strains lack the required proteolytic activity. If the 
sample is toxic, the mice show typical signs of botulism, including fuzzy hair, muscle 
weakness, and respiratory failure that is indicated by a wasp- like narrowed waist, usually 
within four days post- injection. Due to differences in the potencies of BoNTs, the time it takes 
to obtain a positive test result varies with the toxin type, with types A and B being more 
potent that type E toxin. The toxin type is determined by seroneutralization of the toxin with 
specific antitoxins (Centers for Disease Control, 1987). Basically, mice injected with the 
neutralizing antitoxin survive while the others develop botulism. Although the method is very 
sensitive, with one intraperitoneal mouse lethal dose (MLD) corresponding to 10 pg/ml 
(Smith and Sugiyama, 1988), it is expensive and in terms of clinical use it may require too 
much time to make a diagnosis. Moreover, false-positive test results due to the presence of a 
high number (107) of C. botulinum spores (Mitamura et al., 1982) or endotoxins from gram-
negative bacteria have been reported (Solberg et al., 1985). 
Another type of mouse assay with a more humane end point of local muscle paralysis as 
a consequence of a subcutaneous injection of BoNT type A has been explored (Sesardic et al., 
1996). The non-lethal mouse assay is equal to the conventional bioassay as far as sensitivity 
and specificity are concerned, but it does not cause signs of distress or impaired movements in 
the animals (Sesardic et al., 1996).  
 
Immunological methods 
 
A number of immunoassay formats have been reported for the detection of botulinal 
neurotoxins. The production of detection antibodies against the BoNTs is relatively easy and 
most of the immunoassays are technically simple and rapid to perform (Ekong, 2000). 
However, many of these assays, such as radioimmunoassay (RIA) (Ashton et al., 1985), gel 
diffusion assay (Vermilyea et al., 1968; Ferreira et al., 1981), and passive haemagglutination 
assay (PHA) (Johnson et al., 1966) have poor sensitivities or specificities, which decreases the 
diagnostic value of the methods. The most widely used assay format is enzyme-linked 
immunosorbent assay (ELISA) (Notermans et al., 1978) with a variety of modifications 
(Doellgast et al., 1993; Roman et al., 1994). ELISA-based formats may reach sensitivities 
similar to the mouse bioassay (Dezfulian and Bartlett, 1984; Shone et al., 1985; Ekong et al., 
1995; Ferreira et al., 2003). ELISA procedures for the detection of BoNTs in clinical 
specimens (Poli et al., 2002) as well as in foods have been reported (Shone et al., 1985; Potter 
et al., 1993; Rodriguez and Dezfulian, 1997; Ferreira et al., 2001).  
 
Endopeptidase assay 
 
The fact that botulinum neurotoxin possesses a highly specific zinc-endopeptidase activity 
with selected targets in the synaptic vesicle/synaptic membrane docking system has inspired 
the development of an in vitro assay for its detection. The endopeptidase assay is based on 
specific cleavage of the SNARE proteins by BoNTs. Methods for the detection of BoNT types 
A (Ekong et al., 1997; Hallis et al., 1996), B (Hallis et al., 1996; Wictome et al., 1999a, b), 
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and E (Ekong et al., 1999) have been described. The rapid method provides a sensitivity 
similar to or even better than that of the mouse assay (Wictome et al., 1999b). No cross-
reactivity between different toxin types has been reported. However, with the type B toxin 
assay, an increased likelihood of false-negative results has been reported due to the 
serotypical differences between BoNT type B produced by the nonproteolytic and proteolytic 
C. botulinum (Wictome et al., 1999b). 
 
2.3.2 Clostridium botulinum  
 
Culture methods 
 
The conventional detection and isolation of C. botulinum is based on culturing and the 
subsequent detection of culture toxicity by the mouse assay (Kautter and Solomon, 1977). In 
suspect cases of human botulism, the samples are cultivated as such, as well as treated with 
ethanol in order to eliminate vegetative bacteria but not bacterial spores (Nordic Committee 
on Food Analysis, 1991b). Strict anaerobic techniques, including deoxygenation of culture 
media and anaerobic incubation, are required for the successful cultivation of C. botulinum. 
The routine media include chopped meat-glucose-starch (CMGS) medium (Centers for 
Disease Control and Prevention, 1998), cooked meat medium (Robertson, 1916; Quagliaro, 
1977), tryptone-peptone-glucose-yeast extract (TPGY) broth, sometimes supplemented with 
trypsin (TPGYT) (Lilly et al., 1971), and reinforced clostridial medium (RCM) (Gibbs and 
Hirsch, 1956). Blood agar and egg yolk agar (EYA) (Hauschild and Hilsheimer, 1977) serve 
as the most common plating media, with EYA enabling the lipase reaction typical for 
C. botulinum and certain other clostridia. A few selective media have been developed for 
C. botulinum (Dezfulian et al., 1981; Mills et al., 1985; Silas et al., 1985). These media 
improve the isolation of some C. botulinum strains (Glasby and Hatheway, 1985) but, 
however, they do not allow the growth of all C. botulinum strains (Whitmer and Johnson, 
1988). The identification of botulinum toxin in and around C. botulinum colonies grown on 
agar plates by immunoblotting and immunodiffusion procedures facilitates the identification 
of the organism, but it may lack specificity like other immunological techniques (Ferreira et 
al., 1981; Dezfulian and Batrlett, 1985; Goodnough et al., 1993). The isolation of 
C. botulinum from various sources is frequently complicated by the presence of nontoxigenic 
C. botulinum-like cultures (Lee and Riemann, 1970a; Broda et al., 1998).  
 
Biochemical test systems 
 
Rapid test systems based on various growth-dependent and non-growth-dependent 
biochemical reactions have been developed for the identification of anaerobic bacteria. 
Contradictory reports on the ability of the tests to identify Clostridium spp. have been 
published: various tests have been able to correctly identify from not more than 54% to as 
much as 96% of the clostridial strains studied to the species level (Gresser et al., 1984; 
Burlage and Ellner, 1985; Head and Ratnam, 1988; Marler et al., 1991). C. botulinum was 
reported to be correctly identified by the Rapid ID 32 A system to the genus level but not to 
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the species level (Brett, 1998). Factors such as the incubation environment (Peiffer and Cox, 
1993), incubation time (Gresser et al., 1984), and the concentration of cell suspension (Brett, 
1998) have been reported to drastically affect the success of identification, thus reducing the 
reliability of the tests. 
 
Molecular detection methods 
 
The molecular detection of C. botulinum typically involves the detection of the BoNT gene, 
indicating the presence of the organism in a sample. The molecular approaches include the 
sensitive and specific polymerase chain reaction (PCR) and the use of molecular probes 
(Campbell et al., 1993; Franciosa et al., 1994). In PCR, a gene locus determined by specific 
oligonucleotide primers is amplified by a thermotolerant polymerase enzyme. The 
amplification product is then visualized in agarose gels. A labelled molecular probe may be 
further hybridised to a homologous DNA sequence and visualized immunologically.  
The reported sensitivities of PCR and gene probe assays for different C. botulinum types 
in various sample materials vary from 1-2.5 pg of DNA (Szabo et al., 1994; Takeshi et al., 
1996) to 0.3 ng of DNA (Craven et al., 2002), 0.1 – 103 cfu or spores/g of food (Fach et al., 
1993; Fach et al., 1995; Sciacchitano and Hirshfield, 1996; Aranda et al., 1997; Braconnier et 
al., 2001; Córdoba et al., 2001), 10-103 cfu/g of faeces (Dahlenborg et al., 2001, 2003), or 10-
103 cells or spores in environmental samples (Franciosa et al., 1996; Williamson et al., 1999). 
Nested PCR protocols involve several subsequent amplifications, thus increasing the assay 
sensit ivity in e.g. faecal samples (Kakinuma et al., 1997; Dahlenborg et al., 2001). The 
disadvantage of PCR detection directly from a sample is the possible detection of dead cells 
due to intact DNA after cell lysis. This problem is overcome by combining enrichment 
procedures with the PCR protocol (Hielm et al., 1996). Alternatively, reverse transcription-
PCR (RT-PCR) in which gene expression is detected rather than the gene itself, may be 
employed to distinguish viable and dead bacterial cells. A quantitative RT-PCR protocol for 
C. botulinum has been described (McGrath et al., 2000).  
 
Molecular typing methods 
 
Molecular typing methods enable the genomic analysis of bacterial strains, and they have 
been applied to study the genetic diversity of C. botulinum (Lin and Johnson, 1995; Hielm et 
al., 1998a; Hielm et al., 1998b; Hyytiä et al., 1999a) and in tracing the causative agents in 
botulism outbreaks (Korkeala et al., 1998; Austin,  2001). Pulsed-field gel electrophoresis 
(PFGE) has an excellent discriminatory power and reproducibility, while a PCR-based 
method, randomly amplified polymorphic DNA assay (RAPD) is less reproducible but can be 
quickly performed. The application of rRNA gene restriction pattern analysis (ribotyping) has 
been used to identify bacterial species yielding distinct patterns for group I and II 
C. botulinum (Hielm et al., 1999).  
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Quantification techniques 
 
Conventional plating on anaerobic media and most probable number (MPN) technique 
combined with either visual or PCR detection of growth (Hielm et al., 1996), are commonly 
employed in order to quantify C. botulinum in a sample. Plating may be complicated by the 
presence of oxygen or NaCl in the plating medium (Montville, 1984), and to obtain an 
optimal quantification of C. botulinum, a heat-shock may be required (Montville, 1981). A 
more sophisticated approach is real- time PCR, based on the quantification of amplified DNA. 
The method has been applied for nonproteolytic C. botulinum type E to be monitored in fish 
(Kimura et al., 2001). Competitive RT-PCR is based on the rate of BoNT gene expression, 
and it has been applied in the quantification of nonproteolytic C. botulinum type E (McGrath 
et al. 2000). 
 
2.4 Prevalence of nonproteolytic Clostridium botulinum  in foods 
 
Nonproteolytic C. botulinum is widely spread in the environment predominating in mild 
aquatic environments in the Northern hemisphere, including Northern Europe (Johannsen, 
1962, 1963; Cann et al., 1965; Kravchenko and Shishulina, 1967; Huss et al., 1974; Ala-
Huikku et al., 1977; Huss, 1980; Hielm et al., 1996; Hielm et al., 1998b, c), Alaska and 
Northern parts of the United States (Eklund and Poysky, 1965, 1967; Craig and Pilcher, 1967; 
Nickerson et al., 1967; Bott et al., 1968; Cockey and Tatro, 1974; Miller, 1975; Smith, 1975, 
1978; Sayler et al., 1976), Canada (Laycock and Loring, 1972), Japan (Yamamoto et al., 
1970; Yamakawa et al., 1988; Yamakawa and Nakamura, 1992), and Western Asia 
(Tanasugarn, 1979; Haq and Suhadi, 1981; Dhaked et al., 2002). The nonproteolytic 
C. botulinum types B and E are generally more prevalent in nature than type F. The 
prevalence and spore counts of type E in the environment seem to be somewhat higher in the 
Nordic countries (Johannsen, 1962, 1963; Cann et al., 1967; Cann et al., 1968; Huss et al., 
1974; Ala-Huikku et al., 1977; Huss, 1980; Hielm et al., 1996; Hielm et al., 1998b; Hielm et 
al., 1998c) than in other European countries, in which type B seems to predominate (Zaleski 
et al., 1973; Haagsma, 1974; Burns and Williams, 1975; Smith and Moryson, 1975, 1977; 
Borland et al., 1977; Smith et al., 1977, 1978, 1987; Notermans et al., 1979; Smith and 
Milligan, 1979; Smith and Young, 1980; Sonnabend  et al., 1987; Klarmann, 1989; Notermans 
et al., 1989; Ortiz and Smith, 1994). The Baltic Sea has been suggested to be one of the most 
highly contaminated areas in the world with respect to nonproteolytic C. botulinum type E 
(Hielm et al., 1998c).  
 
2.4.1 Unprocessed foods 
 
As a consequence of the high prevalence of nonproteolytic C. botulinum in the environment 
the spores may contaminate raw foods, particularly fish (Table 1). Only a few reports on the 
presence of nonproteolytic C. botulinum in raw meats (Klarmann, 1989) and vegetables 
(Johannsen, 1963; Hauschild et al., 1975) have been published (Table 1). Compared to 
environmental contamination, the prevalence and the average counts of nonproteolytic 
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C. botulinum in raw foods are generally lower (Table 1). In fish (Johannsen, 1963; Huss et al., 
1974; Miller, 1975; Rouhbakhsh-Khaleghdoust, 1975; Hielm et al., 1998b; Hyytiä et al., 
1998; Hyytiä-Trees et al., 1999), the prevalence and spore counts are higher than in meats 
(Klarmann, 1989), in which nonproteolytic C. botulinum seems to be a rather infrequent 
contaminant (Simunovic et al., 1985) despite the high reported prevalence of spores in faeces 
of pigs and cattle (Dahlenborg et al., 2001, 2003). The majority of the earlier reports on the 
prevalence of C. botulinum in the environment concern C. botulinum type E spores. Most of 
the previous studies concerning types B and F do not report the physiological group of 
C. botulinum. However, the low incubation temperature of 28-30ºC and trypsin activation 
required in the detection and isolation of C. botulinum in these studies suggest that these 
organisms belong to group II (Table1).   
 
2.4.2 Processed foods 
 
A limited number of reports on the prevalence of nonproteolytic C. botulinum in processed 
foods have been published. In comparison with unprocessed foods (Table 1), the mean spore 
counts in the processed foods are as expected lower (Table 2). The prevalence in fish products 
has been most intensively studied (Cann et al., 1966; Pace et al., 1967a; Hayes et al., 1970; 
Rouhbakhsh-Khaleghdoust, 1975; Hyytiä et al., 1998). There are only a few reports on the 
prevalence of nonproteolytic C. botulinum type E and probably nonproteolytic types B and F 
in other products, such as vacuum-packaged meats and cheese (Insalata et al., 1969), 
packaged ready-to-eat foods (Taclindo et al., 1967), and smoked turkey products 
(Abrahamsson and Riemann, 1971) (Table 2). Though these papers do not report the 
physiological group of C. botulinum types B and F, the relatively low incubation temperature 
of 28-30ºC used suggests that these strains belong to group II (Table 2). 
 
2.5 Thermal resistance of nonproteolytic Clostridium botulinum 
spores 
 
Bacterial spores are generally much more heat-resistant than vegetative bacteria. The spores 
of nonproteolytic C. botulinum strains possess a moderate heat resistance as opposed to group 
I C. botulinum. Heating medium and physiological variations between bacterial strains affect 
the heat resistance of bacterial spores. A great variation in the D-values of nonproteolytic 
C. botulinum heated in various foods has been shown (Table 3). As for seafood, generally 
shorter D-values were measured in oyster homogenate (Bucknavage et al., 1990; Chai and 
Liang, 1992) than in cod homogenate (Gaze and Brown, 1990), crawfish (De Pantoja, 1986), 
and crabmeat (Lynt et al., 1977, 1983; Cockey and Tatro, 1974; Peterson et al., 1997). In 
crabmeat, the D-values measured by Peterson et al. (1997) were generally greater than those 
measured by other authors. This might be a methodological difference, but more probably it 
may be due to the presence of lysozyme or other lytic enzymes in the crabmeat. 
When present in the recovery medium of heat-injured spores, lysozyme and other 
enzymes with similar activities have been reported to increase the apparent heat resistance of  
 
   
Table 1. Prevalence of nonproteolytic Clostridium botulinum in raw foods. 
 
Country 
 
Sample type and size 
 
Positive 
samples 
(%) 
 
Mean spore 
count 
(spores/kg)a 
 
Group II 
C. botulinum 
type 
 
 
Reference 
      
Canada Mushrooms, 450 g NRb 28c Bd Hauschild et al., 1975 
Denmark Fish, NR 65 2.0c E Huss et al., 1974 
Finland Fish, 5 g 7.1 15 E Ala-Huikku et al., 1977 
Finland Fish, 33 g 19 180 E Hyytiä et al., 1998 
Finland Fish skin and intestines, 33 g 10 238 E Hielm et al., 1998b 
Finland Fish roe, 33 g 7.7 58c E Hyytiä et al., 1998 
Germany Fish, intestines, gills, skin , 5 g 30 80c E Hyytiä-Trees et al., 1999 
Germany Meat, NR 36 NEe E Klarmann, 1989  
Indonesia  Fish, 10 g 5.1 5.3 Bd, E, Fd Haq and Suhadi, 1981 
Italy Vegetables, NR 4.3 NE Bd Quarto et al., 1983 
Japan Fish, NR 4.5 NE E, Fd Yamamoto et al., 1970 
Nordic countries Fish intestines, NR 15 NE E Huss and Pedersen, 1979 
Nordic countries Shellfish, NR 14 NE E Huss and Pedersen, 1979 
Norway Fish, NR 11 NE E Tjaberg and Håstein, 1975 
Poland Fish, herring intestines, NR 18 NE E Zaleski et al., 1978 
Russia  Fish, 6 g 35 73 E Rouhbakhsh-Khaleghdoust, 1975 
Sweden Fish, NRb 46 NE E Johannsen, 1963 
Sweden, Norway Fish , 2 g 4.8 25 E Cann et al., 1966; Cann et al., 1967 
Sweden Peels of potato, 6 g 68 197 E Johannsen, 1963 
Thailand Fish intestines, 100 g 2.3 0.02 E Tanasugarn, 1979 
UK Fish, trout, NR 10 NE B, E, F Cann et al., 1975 
UK Fish, NR 1.4 NE B Burns and Williams, 1975 
USA Fish, NR 6.3 NE E Chapman and Naylor, 1966 
USA Fish and seafood, 70g 43 8.0 B, E, F Baker et al., 1990a 
USA Fish and seafood, 100 g 3.6 0.4 B, E, F Baker et al., 1990a 
USA, Alaska Fish, salmon gills and viscera, NR 1.2 NE E Houghtby and Kaysner, 1969 
USA, Alaska Fish, salmon viscera, roe, and flesh, 1 g 4.9 50 E Miller, 1975 
USA, East cost Fish intestines, NR 4.5 < 43 c E Nickerson et al., 1967 
USA, Great Lakes Fish, intestinal contents, NR 17 NE E Bott et al., 1966 
   
Table 1 continues. 
 
Country 
 
Sample type and size 
 
Positive 
samples 
(%) 
 
Mean spore 
count 
(spores/kg)a 
 
Group II 
C. botulinum 
type 
 
 
Reference 
      
USA, Great Lakes Fish intestinal contents, NR 11 NE E Bott et al., 1967 
USA, Milwaukee Fish, fresh and frozen, > 10 g 8.7 < 9.1 Bd, E Pace et al., 1967a; Pace et al., 1967b 
USA, West coast Fish, gills and viscera, NR 9.5 NE Bd, E Craig and Pilcher, 1967 
USA, West coast Crab, NR 53 NE Bd, E Eklund and Poysky, 1967 
USA, West coast Shellfish, NR 23 NE B d, E  Craig et al., 1968 
      
a Mean spore count extrapolated from all data reported, using the MPN technique. 
b NR, not reported. 
c Mean spore count calculated from the actual numbers reported by the authors. 
d The physiological group of C. botulinum types B and F was not indicated, but an incubation temperature of 28-30ºC was used and/or trypsin activation was 
required in the detection of types B and F toxins. 
e NE, not estimated. 
 
   
Table 2. Prevalence of nonproteolytic Clostridium botulinum in processed foods. 
 
Country 
 
Sample type and size 
 
Positive 
 Samples (%) 
 
Group II 
C. botulinum  
type 
 
 
Mean spore  
count  
(spores/kg)a 
 
Reference 
      
Finland Vacuum-packaged hot-smoked fish, 33 g 7.0 E 35b Hyytiä et al., 1998 
Finland Vacuum-packaged cold-smoked fish, 33 g 3.0 E 160b Hyytiä et al., 1998 
Finland Air-packaged hot-smoked fish, 33 g 3.3 E 45b Hyytiä et al., 1998 
Japan Honey, 20 g 8.3 Fc 30-60 Nakano and Sakaguchi, 1991 
Russia  Salted and smoked fish, 6 g 11 Bc, E 19.6 Rouhbakhsh-Khaleghdoust, 1975 
UK Vacuum-packaged fish, 2 g 0.8 E 3.9 Cann et al., 1966 
USA Vacuum-packaged meats and cheese, NRd 1.0 Bc NR Insalata et al., 1969 
USA, West coast Air-packaged smoked fish, 5-10 g 4.6 E <9.4 Hayes et al., 1970 
USA, Milwaukee Smoked fish, > 10 g 1.3 Bc, E <1.3 Pace et al., 1967a 
USA Packaged ready-to-eat foods, 24 g 1.8 Bc, E 0.8 Taclindo et al., 1967 
USA Smoked turkey, 30 g 2.4 Bc 0.8 Abrahamsson and Riemann, 1971 
USA Venison jerky, NR NR F NR Midura et al., 1972 
      
a Mean spore count extrapolated from all data reported, using the MPN technique.  
b Mean spore count calculated from the actual spore numbers reported by the authors. 
c The physiological group of C. botulinum types B was not indicated, but an incubation temperature of 28-30ºC was used in the detection of types B and F toxins. 
d NR, not reported.
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nonproteolytic C. botulinum spores (Alderton et al., 1974; Peck et al., 1992a, b; Peck et al., 
1993). It has been suggested that these enzymes are able to permeate the heat- injured spore 
coat and induce germination by hydrolyzing peptidoglycan in the spore cortex (Gould, 1989). 
A total of 0.1% to as much as 20% of a nonproteolytic C. botulinum spore population have 
been reported to be naturally permeable to lysozyme possessing a higher measured heat 
resistance than spores that are not permeable to lysozyme (Peck et al., 1992a, b; Peck et al., 
1993). This explains the biphasic thermal destruction curve, where spores non-permeable to 
lysozyme are destroyed more rapidly than those permeable to lysozyme (Peck et al., 1992a, 
b). Concerns regarding the safety of minimally heat-treated foods have arisen in the food 
industry, as lysozyme and other lytic enzymes are present in a number of foods (Proctor and 
Cunningham, 1988; Scott and Bernard, 1985; Lie et al., 1989; Peck and Stringer, 1996; 
Stringer and Peck, 1996; Stringer et al., 1999). The impact of lysozyme on the heat resistance 
of spores heated in various media is clearly demonstrated in Table 4. C. botulinum type E 
spores were shown to possess a higher heat resistance when heated in raw fish mince than 
when heated in autoclaved fish (Alderman et al., 1972), probably indicating a higher activity 
of lytic enzymes in raw foods than in processed foods (Lund and Peck, 1994).  
A tailed thermal destruction curve without using lysozyme in the recovery medium was 
reported by Smelt (1980). The biphasic curve was explained by a mere genetic heterogeneity 
among the spore population, with a small subpopulation being more heat resistant than the 
rest of the spores. Differences in thermal inactivation kinetics within a bacterial spore 
population have also been suggested to explain nonlinear thermal inactivation curves 
(Whiting, 1995; Peleg and Cole, 2000). 
The aw of the heating medium seems to have a considerable effect on the thermal destruction 
of C. botulinum spores. The greatest heat resistance at 110ºC was observed for C. botulinum 
type E spores at aw 0.8 to 0.9 and only a slight decrease in the heat resistance followed when 
the aw was decreased to 0.2 (Murrell and Scott, 1957). However, when the aw was increased to 
0.998, the heat resistance of the type E spores decreased drastically by a factor of 30 000 
(Murrell and Scott, 1957). The effect of ‘moist’ heat has thereafter been used to facilitate the 
hot-smoking of fish products. Processing at 82ºC for 30 min, the heat treatment officially 
recommended for the commercial hot-smoking of fish in the US in the 1960’s (City of 
Milwaukee, 1964; Anonymous, 1964), combined with an ambient relative humidity (RH) of 
70% inside the smoking chamber was sufficient to eliminate C.  botulinum type E spores in 
whitefish chubs by a factor of 105. When the same heat treatment was employed in the 
presence of a lower RH, growth and toxin production from 105 to 106 type E spores was 
observed (Christiansen et al., 1968; Alderman et al., 1972; Pace et al., 1972).  
The z-values (the temperature gradient [ºC] yielding a 10-fold change in the D-value) 
reported for nonproteolytic C. botulinum spores heated in various media are typically around 
6-9ºC, but z-values around 4 to 5ºC (Lynt et al., 1983; Chai and Liang, 1992) to as high as 
16.5ºC have been reported (Scott and Bernard, 1982) (Table 3).  
 
   
Table 3. Heat resistance of spores of nonproteolytic Clostridium botulinum heated in various media. 
 
Heating medium 
 
Group II 
C. botulinum 
type 
 
Temperature 
(°C) for 
D-value 
 
D-value (min) 
 
Temperature 
range (°C) for 
 z-value 
 
 
z-value (°C) 
 
Reference 
       
Phosphate buffer B 77.5 4.0-103   Smelt, 1980 
Phosphate buffer B 80.0 0.6-2.3a   Juneja et al., 1995 
Phosphate buffer B 85.0 2.5-51.0 85.0-90.0 6.3a Smelt, 1980 
Phosphate buffer B 87.5 1.5-24.0   Smelt, 1980 
Phosphate buffer B 90.0 0.4-8.3   Smelt, 1980 
Phosphate buffer E 77.5 1.5-38.0   Smelt, 1980 
Phosphate buffer E 80.0 0.4-3.9a   Juneja et al., 1995 
Phosphate buffer E 80.0 1.2-36.0 80.0-87.5 8.3-9.4a Smelt, 1980 
Phosphate buffer E 82.5 0.5-23.6   Smelt, 1980 
Phosphate buffer E 85.0 0.3-10.4   Smelt, 1980 
Phosphate buffer E 87.5 0.2-6.1   Smelt, 1980 
Phosphate buffer F 73.9 9.1-12.7 71.1-85.0 5.2-6.7a Lynt et al., 1983 
Phosphate buffer F 76.6 1.7-6.6   Lynt et al., 1983 
Phosphate buffer F 79.4 0.9-2.1   Lynt et al., 1983 
Phosphate buffer F 82.2 0.3-0.8   Lynt et al., 1983 
Phosphate buffer F 85.0 0.4   Lynt et al., 1983 
Pork and pea broth B 82.2 1.5-32.3 75.0-100.0 6.5-16.5 Scott and Bernard, 1982 
Pork and pea broth E 82.2 0.3 75.0-100.0 8.7 Scott and Bernard, 1982 
Phosphate buffer, Lb B 75.0 283   Peck et al., 1993 
Phosphate buffer, L B 80.0 2.5-4.3a   Juneja et al., 1995 
Phosphate buffer, L B 85.0 73.6-90 85.0-95.0 7.6 Peck et al., 1993 
Phosphate buffer, L B 90.0 18.1   Peck et al., 1993 
Phosphate buffer, L B 95.0 4.6   Peck et al., 1993 
Phosphate buffer, L E 80.0 1.0-4.5a   Juneja et al., 1995 
Phosphate buffer, L E 85.0 48.3 85.0-95.0 8.3 Peck et al., 1993 
Phosphate buffer, L E 90.0 12.6   Peck et al., 1993 
Phosphate buffer, L E 90.6 13.5   Alderton et al., 1974 
Phosphate buffer, L E 95.0 3.2   Peck et al., 1993 
Phosphate buffer, L E 93.3 3.8   Alderton et al., 1974 
   
Table 3 continues. 
 
Heating medium 
 
Group II 
C. botulinum 
type 
 
Temperature 
(°C) for 
D-value 
 
D-value (min) 
 
Temperature 
range (°C) for 
 z-value 
 
 
z-value (°C) 
 
Reference 
       
Distilled water, L E 90.6 5.0   Alderton et al., 1974 
Pork and pea broth, L B 82.2 28.2-2224   Scott and Bernard, 1985 
Pork and pea broth, L E 82.2 24.2   Scott and Bernard, 1985 
Crabmeat B 88.9 12.9 88.9-94.4 8.5 Peterson et al., 1997 
Crabmeat B 90.6 8.2   Peterson et al., 1997 
Crabmeat B 92.2 5.3   Peterson et al., 1997 
Crabmeat B 94.4 2.9   Peterson et al., 1997 
Crabmeat E 73.9 6.2-13 73.9-85.0 6.4-8.1a Lynt et al., 1977, 1983 
Crabmeat E 76.6 1.7-4.1   Lynt et al., 1977, 1983 
Crabmeat E 79.4 1.1-1.7   Lynt et al., 1977, 1983 
Crabmeat E 82.2 0.5-0.7   Lynt et al., 1977 
Crabmeat E 82.2 0.5-0.8   Lynt et al., 1983 
Crabmeat E 85.0 0.2a   Cockey and Tatro, 1974 
Crabmeat E 85.0 0.3   Lynt et al., 1977, 1983 
Crabmeat F 76.6 9.5 76.6-85.0 6.6a Lynt et al., 1983 
Crabmeat F 79.4 3.6   Lynt et al., 1983 
Crabmeat F 82.2 1.2   Lynt et al., 1983 
Crabmeat F 85.0 0.5   Lynt et al., 1983 
Crawfish E 80.0 4.9-7.0 80.0-95.0 8.0-14.5 DePantoja, 1986 
Crawfish E 85.0 6.7-8.8   DePantoja, 1986 
Crawfish E 90.0 2.5-3.1   DePantoja, 1986 
Oyster homogenate E 73.9 2.0-9.0 73.9-82.2 4.2-6.2 Chai and Liang, 1992 
Oyster homogenate E 75.0 1.3-5.3   Chai and Liang, 1992 
Oyster homogenate E 76.7 0.7-2.7   Chai and Liang, 1992 
Oyster homogenate E 79.4 0.3-1.0   Chai and Liang, 1992 
Oyster homogenate E 80.0 0.8 70.0-80.0 7.6 Bucknavage et al., 1990 
Oyster homogenate E 82.2 0.1-0.4   Chai and Liang, 1992 
Cod homogenate B 75.0 53.9 75.0-92.0 8.6 Gaze and Brown, 1990 
Cod homogenate B 80.0 18.3   Gaze and Brown, 1990 
   
Table 3 continues. 
 
Heating medium 
 
Group II 
C. botulinum 
type 
 
Temperature 
(°C) for 
D-value 
 
D-value (min) 
 
Temperature 
range (°C) for 
 z-value 
 
 
z-value (°C) 
 
Reference 
       
Cod homogenate B 85.0 4.0   Gaze and Brown, 1990 
Cod homogenate B 90.0 1.1   Gaze and Brown, 1990 
Cod homogenate B 92.0 0.6   Gaze and Brown, 1990 
Cod homogenate E 75.0 58.5 75.0-92.0 8.3 Gaze and Brown, 1990 
Cod homogenate E 80.0 15.1   Gaze and Brown, 1990 
Cod homogenate E 85.0 4.8   Gaze and Brown, 1990 
Cod homogenate E 90.0 0.8   Gaze and Brown, 1990 
Cod homogenate E 92.0 0.6   Gaze and Brown, 1990 
Whitefish chubs E 80.0 1.6-4.3 80.0-90.0 5.7-7.6a Crisley et al., 1968 
Turkey slurry, L B 75.0 32.5 70.0-90.0 9.4 Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L B 80.0 15.2   Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L B 85.0 4.9   Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L B 85.0 7.8 80.0-90.0 10.8 Juneja and Eblen, 1995 
Turkey slurry, L B 90.0 0.8   Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L B 90.0 1.1   Juneja and Eblen, 1995 
Turkey slurry, L E 75.0 18.1 70.0-90.0 9.9 Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L E 80.0 13.4   Juneja et al., 1995; Juneja, 1998 
Turkey slurry, L E 85.0 1.2   Juneja et al., 1995; Juneja, 1998 
Carrot homogenate B 75.0 19.4 75.0-92.0 9.8 Gaze and Brown, 1990 
Carrot homogenate B 80.0 4.2   Gaze and Brown, 1990 
Carrot homogenate B 85.0 1.6   Gaze and Brown, 1990 
Carrot homogenate B 90.0 0.4   Gaze and Brown, 1990 
Carrot homogenate B 92.0 0.4   Gaze and Brown, 1990 
Carrot homogenate E 75.0 18.1 70.0-90.0 9.8 Gaze and Brown, 1990 
Carrot homogenate E 80.0 4.3   Gaze and Brown, 1990 
Carrot homogenate E 85.0 0.7   Gaze and Brown, 1990 
Carrot homogenate E 90.0 0.5   Gaze and Brown, 1990 
       
a Extrapolated from thermal destruction data reported by authors. 
b L, heating medium containing added lysozyme. 
  
Table 4. Time to growth or toxin production from 104 to 106 spores of nonproteolytic C. botulinum types B, E, and F processed in laboratory media and 
vacuum-packaged seafood stored at 10ºC or below.  
 
Heat process 
 
Medium 
 
Process 
temperature (ºC) 
 
 
Process 
time (min) 
 
Storage  
temperature 
(ºC) 
 
Time  
to toxicity 
(d) 
 
pH 
 
NaCl  
content 
(% v:v) 
 
Type and 
number  
of spores 
 
Reference 
         
Meat medium 85 11.4 5 58 6.5 NRa BEF 106 Fernández and Peck, 1997 
Meat medium 85 18.1 5 104 6.5 0.6 BEF 106 Graham et al., 1996a 
Meat medium 85 11.4 8 24 6.5 NR BEF 106 Fernández and Peck, 1997 
Meat medium 85 19.2 8 53 6.1-6.3 NR BEF 106 Peck et al., 1995 
Meat medium 85 17.3 8 >60 6.1-6.3 NR BEF 106 Peck et al., 1995 
Meat medium 85 23.3 8 >90 6.5 NR BEF 106 Fernández and Peck, 1997 
Meat medium 85 17.5 8 >91 6.5 0.6 BEF 106 Graham et al., 1996a 
Meat medium, Lb 85 23.3 5 >90 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 85 35.7 5 >90 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 90 10.3 5 >90 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
PYGS medium, L 90 1.0 5 >161 6.8 NR BEF 106 Stringer et al., 1997 
Meat medium, L 85 18.1 8 43 6.5 2.5 BEF 106 Graham et al., 1996a 
Meat medium, L 85 35.7 8 48 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 90 10.3 8 54 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 90 10.9 8 58 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 85 23.3 8 61 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 85 18.1 8 64 6.5 0.6 BEF 106 Graham et al., 1996a 
Meat medium, L 85 52.0 8 >90 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
Meat medium, L 90 15.3 8 68 6.4-6.6 NR BEF 106 Fernández and Peck, 1999 
PYGS medium, L 90 15.0 10 7 6.8 1.5 B 105.1 Stringer and Peck, 1997 
PYGS medium, L 90 15.0 10 14 6.8 3.0 B 105.1 Stringer and Peck, 1997 
PYGS medium, L 90 60.0 10 >161 6.8 NR BEF 106 Stringer et al., 1997 
Crab analog 85 15.0 c 10 >120 7.2 2.1 B 104 Peterson et al., 2002 
Hot-smoked salmon 92.2 45.0 d 10 >120 7.2-7.4 1.0-2.0 BE 106 Eklund et al., 1988 
         
a NR, not reported. 
b L, lysozyme was added in the recovery medium of heat-damaged spores. 
c Process time does not include the effect of the come-up time of 12 min to the target temperature of 85ºC.   
d Process time includes a come-up time of 27.7 min to the target temperature of 92.2ºC. 
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2.6 Risk of nonproteolytic Clostridium botulinum  in REPFED 
products 
 
2.6.1 REPFED products 
 
The increased demand among consumers for convenient and fresh- like foods with minimal 
thermal processing and preservation has led to a tremendous increase in the sales of REPFED 
food products in Europe. These foods are given mild heat treatments with maximum process 
temperatures typically reaching 65-95ºC, which may allow for the survival of bacterial spores. 
The heat treatment is followed by rapid cooling and chilled storage at 1 to 8ºC. The 
microbiological quality of REPFED foods thus relies mainly upon the mild heat treatment and 
a refrigerated storage temperature. As REPFED products are typically packaged under 
vacuum or in MA ensuring anaerobic conditions, the shelf lives established for these foods 
may be as long as 42 d. This has raised concern in regard to food safety due to the hazard 
caused by spore-forming bacteria (Del Torre et al., 1998, 2001), particularly anaerobic 
nonproteolytic C. botulinum (Genigeorgis, 1985; Baker and Genigeorgis, 1989). Three main 
types of REPFED products are being produced: (1) Foods that are first packaged and then 
processed, such as sous vide foods; (2) foods that are processed and then packaged, such as 
vacuum-packaged hot-smoked fish products; and (3) foods that are first cooked, then 
packaged, and finally pasteurized. All types of ingredients are used in the production of 
REPFED foods (Gorris and Peck, 1998).   
 
2.6.2 Factors predisposing to risk caused by nonproteolytic Clostridium 
botulinum in REPFED products 
 
Several factors increase the risk associated with nonproteolytic C. botulinum in REPFED 
foods (Peck, 1997). (1) As an environmental organism, nonproteolytic C. botulinum may 
contaminate the raw materials applied in REPFED technology. (2) The heat treatments 
employed in the production of REPFED products are generally too mild to eliminate bacterial 
spores, whereas they readily destroy the vegetative bacterial flora and thus enable the spore-
formers to germinate and grow in the absence of competitive microflora. (3) Vacuum and 
MA-packaging delay the oxygen-related spoilage resulting in extended shelf lives, and thus 
allow the multiplication of facultatively anaerobic and anaerobic bacteria. (4) Nonproteolytic 
C. botulinum may grow at temperatures as low as 3.0-3.3ºC (Schmidt et al., 1961; Eklund et  
al., 1967a, b; Graham et al., 1997), while the typical storage temperatures measured at the 
retail and consumer level may exceed 10ºC (Evans, 1998). (5) The use of NaCl and 
particularly other preservatives in REPFED foods is limited. (6) Pre-cooked produc ts are not 
always further heated, and toxin production by nonproteolytic C. botulinum may precede the 
sensory spoilage of the product (Post et al., 1985; Garcia et al., 1987; Ikawa and Genigeorgis, 
1987; Gorris and Peck, 1998; Reddy et al., 1999; Lawlor et al., 2000).  
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2.6.3 Control of nonproteolytic Clostridium botulinum in REPFED products 
 
The control of risk caused by nonproteolytic C. botulinum in REPFED products includes the 
elimination of spores present in the raw materials and/or the inhibition of germination and 
growth from spores surviving heat treatment. According to the ACMSF (1992) and ECFF 
(1996) guidelines, the safety of REPFED foods with respect to nonproteolytic C. botulinum 
should be ensured by a 6D heat treatment, reducing the initial number of nonproteolytic 
C. botulinum spores by a factor of 106. A time-temperature combination of 10 min at 90ºC or 
one with equivalent lethality was proposed to ensure a 6D reduction (ACMSF, 1992; ECFF, 
1996). 
If the 6D process can not be guaranteed, the germination and outgrowth of spores 
should be inhibited by other factors (ACMSF, 1992; ECFF, 1996) such as a NaCl content of 
5% (w:v), aw of 0.97 (Ohye and Christian, 1966; Baird-Parker and Freame, 1967; Emodi and 
Lechowich, 1969), or pH below 5.0 (Segner et al., 1966; Lund et al., 1990). Alternatively, a 
storage temperature of <3.0ºC throughout the entire storage period would effectively control 
the risk of growth and toxin formation from nonproteolytic C. botulinum. However, as the 
germination of nonproteolytic C. botulinum occurs at a wider temperature range than growth, 
1 to 50ºC with the optimum being 9 to 25ºC (Strasdine, 1967; Ando and Iida, 1970; Grecz and 
Arvay, 1982; Evans et al., 1997; Plowman and Peck, 2002), even a slight fluctuation in the 
storage temperature may be harmful. 
The application of various gas atmospheres in the MA-packages has been used to 
control botulinal growth in REPFED foods. As opposed to vacuum packaging, air-packaging 
and MA-packaging with 75% CO2 delayed toxin formation at 8ºC from 102 nonproteolytic 
spores in catfish by 3 and 12 d, respectively (Reddy et al., 1997). The inhibitory effect of CO2 
was also demonstrated by the time to toxin production from 104 type E spores in vacuum and 
MA (100% CO2) packaged salmon to be 9 and 12 - >21 d, respectively, at 8ºC (Lindroth and 
Genigeorgis, 1986; Baker et al., 1990b). Moreover, the time to toxin production at 4ºC from 
101.7 nonproteolytic spores was extended from 14 to 28 d by replacing 100% N2 with a 
mixture of 30% CO2 and 70% N2 in MA-packaged turkey (Lawlor et al., 2000). The CO2 
levels of 65, 90, and 100%, combined with O2 at level of 4, 1, and 0%, respectively, allowed 
botulinal growth or toxigenesis at 8ºC in 5, 8, and 20 d, respectively (Post et al., 1985).  
Many preservatives, although rarely used in REFPED technology, have been reported to 
effectively control the growth of nonproteolytic C. botulinum. Sodium lactate at the levels of 
2.4% and 1.8% in sous vide beef and chicken, respectively, stored at 12ºC, was shown to 
delay toxigenesis from 104 spores of nonproteolytic C. botulinum by at least 40 d, whereas in 
sous vide processed salmon a lactate level of 4.8% was required  (Meng and Genigeorgis, 
1994). In cooked turkey with 1% NaCl in brine, a sodium lactate level of 3% prevented 
toxigenesis for 32 d at 12ºC (Meng and Genigeorgis, 1993). Bacteriocins inhibiting the 
growth of C. botulinum in foods (Okereke and Montville, 1991) include nisin (Scott and 
Taylor, 1981a, b; Taylor et al., 1985; Somers and Taylor, 1987) and subtilin (LeBlanc et al., 
1953). In addition to its growth- inhibitory action, nisin has also been reported to decrease the 
heat resistance of bacterial spores (Penna and Moraes, 2002). Lactic acid bacteria have also 
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been shown to inhibit the growth of C. botulinum (Lyver et al., 1998a, b; Skinner et al., 
1999). 
While the inhibition of proteolytic C. botulinum by sodium nitrite has been extensively 
studied (Roberts and Ingram, 1973; Roberts, 1975; Christiansen et al., 1974; Tompkin et al., 
1978; Sofos et al., 1979) reports on its effects on nonproteolytic strains are scarce (Cuppett et 
al., 1987; Hyytiä et al., 1997; Keto-Timonen et al., 2002). In heat processed foods nitrite 
forms the Perigo factor that is inhibitory to C. botulinum (Perigo et al., 1967; Christiansen et 
al., 1973). The use of nitrite, however, is limited in European countries due to its possible 
adverse health effects. In fish products produced in the EU countries the use of nitrite is 
prohibited (European Parliament and the Commission of the European Communities, 1995). 
A large number of other compounds inhibiting nonproteolytic C. botulinum in laboratory 
media or in foods have been widely reviewed (Roberts and Gibson, 1982; Rhodehamel et al., 
1992). However, as the intrinsic preservative factors in REPFED foods are limited, the 
protection from nonproteolytic C. botulinum in REPFED products relies mainly upon heat 
treatment and refrigerated storage (Conner et al., 1989; Gorris and Peck, 1998) (Table 4). 
Tables 4 and 5 list challenge studies with nonproteolytic C. botulinum spores grown in 
various media with or without preceding heat processing, followed by incubation at 
refrigerated or slightly abused temperatures.  
Mathematical models predicting the lag time to growth and time to toxin production 
from unheated and heated spores of nonproteolytic C. botulinum in foods have been 
developed based on large data series obtained in laboratory media and model food media 
(Lindroth and Genigeorgis, 1986; Jensen et al., 1987; Baker and Genigeorgis, 1990; Baker et 
al., 1990b; Genigeorgis et al., 1991; Meng and Genigeorgis, 1993; Graham et al., 1996b; 
Fernández and Peck, 1997; Skinner and Larkin, 1998; Fernández and Peck, 1999, Fernández 
et al., 2001) (Tables 4 and 5). The models typically describe the estimated reduction in spore 
numbers and/or the probability of growth from a single spore when various spore loads are 
treated by different time-temperature combinations and subsequently incubated under a range 
of conditions. However, the commercially available microbiological models do not take into 
account the possible effect of lysozyme present in the foods, or the effect of other process 
parameters such as RH. Moreover, as the data employed in the development of the models are 
often derived from studies using media providing optimal conditions for growth, the models 
frequently generate ‘fail safe’ predictions (Meng and Genigeorgis, 1993; Gould, 1999; Hyytiä 
et al., 1999b). Similarly, the reports on the models predicting a product to be safer than it is, 
suggest an inconsistency between the models and real foods, emphasizing the importance of 
safety evaluations by inoculated pack studies (Hyytiä, 1999; Hyytiä et al., 1999b). 
   
Table 5. Time to growth or toxin production from 1 to 106 spores of nonproteolytic C. botulinum types B, E, and F grown in laboratory media  and various 
foods stored at temperatures below 10ºC.  
 
Medium 
 
Storage 
temperature 
(ºC) 
 
 
Time to 
growth or 
toxigenesis 
(d) 
 
 
Type and 
number of 
spores 
 
pH 
 
NaCl in 
brine (%) 
 
Reference 
       
Laboratory media       
     PYGS medium 3 35-49 BEF 105 6.2 1.0 Graham et al., 1997 
     PYGS medium 4 21-28 BEF 105 6.0-7.0 1.0 Graham et al., 1997 
     PYGS medium 5 14-28 BEF 105 5.7-7.0 1.0 Graham et al., 1997 
     PYGS medium 5 12-13 BEF 106 6.0-6.1 0.1-2.0 Graham et al., 1996b 
     PYGS medium 5 14 BEF 106 6.5 1.5 Fernández et al., 2001 
     PYGS medium with 90% CO2 5 18 BEF 106 6.5 1.5 Fernández et al., 2001 
     PYGS medium 7 8 BEF 106 5.9 2.0 Graham et al., 1996b 
     PYGS medium 8 1-3 BEF 105 5.5-6.0 1.0 Graham et al., 1997 
     PYGS medium with 90% CO2 8 8 BEF 106 6.5 1.5 Fernández et al., 2001 
     Meat medium  8 5-7 BEF 106 6.5 0.6-1.5 Graham et al., 1996a; 
Fernández et al., 2001 
     PYGS medium 8 25 BEF 106 5.3 1.0 Graham et al., 1996b 
Meats       
     Cooked turkey 4 80 BE 103 6.3 1.5 Genigeorgis et al., 1991 
     Cooked turkey 8 7 BE 104 6.2-6.3 0.5 Meng and Genigeorgis, 1993 
     Cooked beef  8 8 BE 104 5.8 NRa Meng and Genigeorgis, 1994 
     Cooked turkey 8 8 BE 104 6.3 1.5 Genigeorgis et al., 1991 
     Cooked chicken 8 16 BE 104 5.9 NR Meng and Genigeorgis, 1993, 1994 
Fish       
     Vacuum-packaged salmon 4 15 BEF 104 6.3 NR Garcia and Genigeorgis, 1987 
     Vacuum-packaged rockfish 4 21 BEF 103 6.7 NR Lindroth and Genigeorgis, 1986 
     Vacuum-packaged shrimps 4 >21 E 103-104 NR NR Garren et al., 1994 
     Vacuum-packaged cod and whiting 4 18 E 101.7 NR NR Post et al., 1985 
     Vacuum-packaged catfish 4 46 E 102 6.6 NR Reddy et al., 1997 
     Air packaged tilapia  4 >47 E 102 6.4 NR Reddy et al., 1996 
     Air-packaged catfish 4 >54 E 102 6.6 NR Reddy et al., 1997 
   
Table 5 continues. 
 
Medium 
 
Storage 
temperature 
(ºC) 
 
 
Time to 
growth or 
toxigenesis 
(d) 
 
 
Type and 
number of 
spores 
 
pH 
 
NaCl in 
brine (%) 
 
Reference 
       
     Vacuum-packaged tilapia  4 >90 E 102 6.4 NR Reddy et al., 1996 
     Sous vide processed salmon 8 8 BE 104 6.4 6.4 Meng and Genigeorgis, 1994 
     Vacuum-packaged salmon 8 3-12 BEF 1-10 6.2-6.4 NR Garcia and Genigeorgis, 1987; 
Garcia et al., 1987; Baker et al., 
1990b 
     Vacuum-packaged salmon and rockfish 8 9 E 104 6.4 NR Baker et al., 1990b 
     MA-packaged salmon, 100% CO2 8 9-15 BEF 10-103 6.2-6.3 NR Garcia and Genigeorgis, 1987; 
Garcia et al., 1987; Baker et al., 
1990b 
 Sous vide processed salmon with  
2.4 % Na- lactate 
8 12 BE 104 6.4 NR Meng and Genigeorgis, 1994 
     Vacuum-packaged sole  8 12 E 104 6.5 NR Baker et al., 1990b 
     MA-packaged rockfish, 100% CO2 8 12-15 BEF 101-103 6.7 NR Lindroth and Genigeorgis, 1986; 
Ikawa and Genigeorgis, 1987 
 Vacuum-packaged rockfish, salmon, sole 
and red snapper 
 
8 
 
12-21 
 
BEF 102-103 
 
6.4-6.7 
 
NR 
Lindroth and Genigeorgis, 1986; 
Ikawa and Genigeorgis, 1987; 
Baker et al., 1990b 
     Vacuum-packaged smoked trout 8 14 E 102 6.2-6.5 1.7-2.1 Dufresne et al., 2000 
     Vacuum-packaged tilapia  8 17 E 102 6.4 NR Reddy et al., 1996 
     Vacuum-packaged cod and whiting 8 17 E 101.7 NR NR Post et al., 1985 
     Air packaged tilapia  8 20 E 102 6.4 NR Reddy et al., 1996 
 Sous vide processed salmon with 
4.8 % Na-lactate 
8 >90 BE 104 6.4 NR Meng and Genigeorgis, 1994 
Vegetables       
     Mushroom 10 5 BEF 103 6.4 NR Carlin and Peck, 1996 
     Asparagus 10 8 BEF 103 5.3 NR Carlin and Peck, 1996 
     Broccoli 10 19 BEF 103 5.5 NR Carlin and Peck, 1996 
       
a NR, not reported. 
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3. AIMS OF STUDY 
 
The aims of the present thesis were to develop the diagnostics of C. botulinum and to improve 
the safety of REPFED foods with respect to nonproteolytic C. botulinum by intensified 
thermal processing. The specific aims were as follows: 
 
1. to evaluate the applicability of commercially available biochemical test 
systems in the identification of Clostridium botulinum (I) 
 
2. to develop a multiplex PCR assay for the detection of Clostridium botulinum 
types A, B, E, and F in pure cultures, food and faecal material (II) 
 
3. to determine the thermal destruction parameters of spores of nonproteolytic 
Clostridium botulinum type E heated in model fish media (III) 
 
4. to evaluate the safety of the thermal processes employed in the production 
of commercial REPFED foods with respect to nonproteolytic C. botulinum 
(III, IV) 
 
5. to develop thermal processes controlling the growth and toxin production 
from 105.3-106 spores of nonproteolytic Clostridium botulinum in REPFED 
products (III-V), and 
 
6. to evaluate the sensory quality of REPFED products shown to control the 
growth and toxin production from 105.3-106 spores of nonproteolytic 
Clostridium botulinum (III-V). 
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4. MATERIALS AND METHODS 
 
4.1 Bacterial strains and culturing (I-V) 
 
A total of 95 strains of proteolytic and nonproteolytic C. botulinum and 37 strains of other 
bacterial species were used in the evaluation and development of diagnostic methods in 
studies I and II (I and II, Table 1). The strain mixtures used in studies III to V included 
nonproteolytic C. botulinum types B (706B [studies III, IV]; 2B [IV]; 17B [IV]), E (31-2570E 
[III]; 4062E [III]; C-60E [III]; Beluga E [V]; 211E [V]; 250E [V]), and F (FT10F [III]) 
strains. All Clostridium spp. spore suspensions were prepared according to Food and 
Agricultural Organization (1991) and enumerated as described (Doyle, 1991), and stored at 
4ºC until use. 
All C. botulinum strains were cultivated in TPGY broth (Food and Agricultural 
Organization, 1991) at 30 (group II organisms) to 37ºC (group I organisms) for 2 to 3 d. 
Thereafter, in study I the cultures were grown on blood agar plates at respective temperatures 
for 2 to 3 d prior to use in the biochemical test systems. In studies II-V, the broth cultures 
were further transferred to fresh TPGY medium for 16 to 18 h at respective temperatures in 
order to synchronize the logarithmic growth of the organisms. In study II, the food and faecal 
samples inoculated with spores of C. botulinum were initially diluted in peptone water (1:9 
w:v) prior to the two-step culturing. 
 
4.2 Evaluation of biochemical test systems and development of 
multiplex PCR assay (I, II) 
 
4.2.1 Biochemical tests (I) 
 
The biochemical test systems evaluated in study I included API 20 A (bioMérieux SA, 
Marcy- l’Etoile, France), Rapid ID 32 A (bioMérieux SA), and RapID ANA II (Innovative 
Diagnostic Systems, Inc., Norcross, GA, USA). All tests were performed according to the 
manufacturers’ instructions.  
 
4.2.2 Multiplex PCR detection of Clostridium botulinum (II) 
 
The multiplex PCR developed in study II for the detection of C. botulinum types A, B, E, and 
F was preceded by a cell wash and lysis procedure (Franciosa et al., 1994; Hielm et al., 1996) 
to release the bacterial DNA. Four primer pairs with equal melting temperatures, each pair 
being specific for BoNT type A, B, E, or F (study II, Table 2), were designed by Primer 3 
software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA) based on 
published BoNT gene sequences (Bintz et al., 1990; Thompson et al., 1990; East et al., 1992; 
Poulet et al., 1992; Whelan et al., 1992a, b; Elmore et al., 1995). The 50-µl reaction mixture 
consisted of 1 µl of cell lysate as template, 0.3 µM of each primer (Sigma-Genosys Ltd., 
Cambridgeshire, UK), 220 nM of each deoxynucleotide triphosphate  (dNTP; Finnzymes, 
Espoo, Finland), 32 mM Tris-HCl, 80 mM KCl, 4.8 mM MgCl, and 2U of DNA polymerase 
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(DynaZyme, Finnzymes). Each of 28 PCR cycles included denaturation at 95ºC for 30 s, 
annealing at 60ºC for 25 s, and extension at 72ºC for 1 min 25 s, followed by a final extension 
at 72ºC for 3 min. The PCR amplicons were detected in 2% agarose gels (iD.N.A Agarose, 
BioWhittaker Molecular Applications, Rockland, ME, USA) stained with ethidium bromide 
with comparison to standard-weight molecular markers.  
The detection limit of the assay was tested with minced meat, fish, and faecal samples 
inoculated with 10-2 to 103 spores/g of sample material. A total of 72 natural food samples 
consisted of meat, fish, and vegetables were investigated for the presence of C. botulinum 
types A, B, E, and F by the multiplex PCR assay. 
 
4.3 Determination of heat-resistance parameters for nonproteolytic 
Clostridium botulinum spores heated in model fish media (III) 
 
Model media (pH 6.4) consisting of rainbow trout or whitefish were prepared by modification 
of a method for meat medium (Peck et al., 1995) (study III). Tubes containing 5-ml aliquots 
of the media were inoculated with 106 nonproteolytic C. botulinum type E spores and exposed 
to heat treatments of 0.5 to 450 min at various target temperatures in the range of 75 to 93ºC, 
followed by a rapid cooling. Uninoculated test tubes were used to monitor the temperature 
data (Envic DP-158, Envic, Turku, Finland) of the thermal treatments. These data were 
converted into equivalent process times at the target temperature by the formula 10(T-Tref)/z, 
where T is the actual temperature and Tref is the target temperature. A z-value of 7ºC was used 
(ECFF, 1996). The tubes were cultured with TPGY medium supplemented with hen egg white 
lysozyme (625 IU/ml, Sigma Chemical Co., St. Louis, MO, USA) in order to detect the heat-
resistant spore fraction. The tubes were stored at 30ºC for 90 d and observed for growth at 
regular intervals. In addition, the numbers of spores surviving each heat treatment were 
determined by MPN with the detection limit being 2 spores. Growth was observed visually. 
The survival data were fitted to biphasic thermal destruction curves by linear regression 
analysis, yielding D-values and the percentage of heat-resistant spores at various 
temperatures. The z-values were extrapolated from the thermal death time (TDT) curves. 
 
4.4 Safety evaluation and development of thermal processes 
employed in the REPFED industry (III-V) 
 
The safety of five fish hot-smoking processes (III) and 16 sous vide processes (IV) employed 
in the Finnish REPFED food industry were evaluated with respect to their lethality to spores 
of nonproteolytic C. botulinum types B and E. The safety evaluation included the estimation 
of a pasteurization (P85ºC) value for each process, describing the equivalent process time at 
85ºC, and inoculated pack stud ies with vacuum-packaged hot-smoked fish and sous vide 
foods (Tables 6 and 7). Based on the safety evaluation, heat processes controlling the growth 
and toxin production from 105.3-106 spores of nonproteolytic C. botulinum type E in fish (III) 
and type B in sous vide meat (V) were developed.  
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4.4.1 Inoculation of REPFED products with Clostridium botulinum (III-V) 
 
The hot-smoked fish products were rainbow trout fillets and whole whitefish (Table 6), and 
the sous vide foods consisted of meat alone, or meat, vegetables, and rice (Table 7). The pH 
and the concentration of NaCl added in the foods varied in the range of 4.7 to 7.6 and 0.2 to 
2.0%, respectively. The product size varied from 530 to 1500 g. The products were inoculated 
with 105.3 to 106 spores of nonproteolytic C. botulinum types B, E, and F, in the mixtures 
described in 4.1. 
 
4.4.2 Thermal processing of REPFED products (III-V) 
 
The fresh unpackaged fish were processed in an electrically controlled smoking chamber 
(Vemag, Kerres, GmbH, Sulzbach/Murr, Germany) and the packaged sous vide products were 
processed in a water autoclave (Stock Pilot Rotor 900 G, Hermann Stock Maschinenfabrik 
GmbH, Neumünster, Germany). All products were exposed to heat treatments equal to 
processing at 85ºC for 0 to 515 min (Tables 6 and 7) as determined by converting the 
temperature data measured during the processes into the equivalent process times at 85ºC by 
using the formula 10(T-Tref)/z, where T is the actual temperature and Tref is 85ºC. The z-values 
of 10.1-10.4ºC (as determined in study III) were used in study III, and a value of 7ºC (ECFF, 
1996) was used in studies IV and V. In study III, relative humidity (%RH) inside the smoking 
chamber was chosen as an additional process parameter. The RH during each hot-smoking 
process was between 10 and 80%. After thermal processing the fish were cooled at room 
temperature for 2 h until packaging (III) and the sous vide products (IV, V) were chilled at 
2ºC.  
 
4.4.3 Packaging and storage of REPFED products (III-V) 
 
The hot-smoked and cooled fish (III) and sous vide products (IV, V) were vacuum-packaged 
(Multivac A 300/16 1986, Multivac Verpackungsmaschinen, Wolfertschwenden, Germany) in 
nylon-polyethylene pouches prior to or after thermal processing, respectively. The fish were 
stored at 8°C for 35 d, and the sous vide foods were stored at 4 or 8ºC for 9 to 37 d. The 
storage times corresponded to the commercial product shelf lives employed in Finland or 
these times extended by 1 to 2 weeks. 
 
4.4.4 Sampling procedures (III-V) 
 
After storage periods of 9 to 37 d at 4 or 8ºC, the REPFED products were analysed for the 
presence and number of viable nonproteolytic C. botulinum organisms by PCR (Franciosa et 
al., 1994; Hielm et al., 1996; Sciacchitano and Hirshfield, 1996) combined with MPN 
technique (Finnish Standards Association, 1994). The presence of botulinum neurotoxin in the 
products was determined according to the Nordic Committee on Food Analysis (Nordic 
Committee on Food Analysis, 1991a), with slight modifications in study IV (Hyytiä et al., 
1997). The bioassays were approved by the Committee on Animal Experimentation of the 
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Faculty of Veterinary Medicine, University of Helsinki. In addition, the pHs of all products 
were measured (Microprocessor pH 537, Wissenschaflich-Technische Werkstätten, Weilheim, 
Germany) in studies III-V. The NaCl content of the fish was measured in study V according 
to the International Organization for Standardization (1989). 
 
4.4.5 Sensory evaluations (III-V) 
 
The sensory quality of the REPFED products was determined by trained panels 1 to 3 d after 
processing (III-V) as well as during and at the end of the storage (IV, V). All the products 
were served at a temperature typical of the product: hot-smoked fish at room temperature and 
sous vide products at 65ºC. In studies III and V a quantitative profiling of various sensory 
attributes (Lawless and Heymann, 1998), including flavour, odour, juiciness, firmness, and 
the degree of cooking in study III, and brownness, greyness, aroma, flavour, and juiciness in 
study V, of products exposed to various heat treatments at 85ºC for 0 to 515 min was used. In 
study IV, a quantitative ranking of the suitability of the sous vide foods, stored at 8ºC for 
various times, to human consumption in reference to a fresh product, was employed using 
appearance and aroma as the sensory attributes (Meilgaard et al., 1987). The details of the 
analytical procedures have been described in the original publications III-V. 
 
4.4.6 Predictive microbiological models (IV) 
 
In study IV, predictions for the lethal effect of the heat treatments on spores of nonproteolytic 
C. botulinum in the sous vide foods were generated by the Food Micro Model (FMM, version 
2.5, Leatherhead Food Research Association, Leatherhead, Surrey, UK). Moreover, the FMM 
and Pathogen Modelling Program (PMP, version 5.0, US Department of Agriculture Eastern 
Regional Research Center, Wyndmore, PA, USA) were used to predict the lag time for 
growth and time-to-turbidity, respectively, from the nonproteolytic C. botulinum spores. The 
FMM thermal death model for nonproteolytic C. botulinum type B, predicting the estimated 
minimum decrease in the spore number, uses process temperature (80 to 95ºC), water-phase 
NaCl concentration (0 to 5%), and pH (4.0 to 7.4) as controlling factors. The two growth 
models (FMM nonproteolytic C. botulinum types B, E, F; PMP type B) take into account the 
storage temperature (FMM 4 to 30ºC, PMP 5 to 28ºC), pH (FMM 5.1 to 7.5, PMP 5.0-7.0), 
water-phase NaCl content (FMM 0 to 4.5%, PMP 0 to 4%), and the initial number of spores 
(PMP 1 to 105CFU/product unit). 
 
4.5 Statistical analyses (I, III, V) 
 
The sensitivity and specificity of the biochemical test systems for C. botulinum evaluated in 
study I were determined (Martin et al., 1987). In study III, linear regression analysis was 
employed to generate the biphasic thermal destruction curves for nonproteolytic C. botulinum 
type E spores heated in model fish media at 75 to 93ºC. Analysis of variance, taking into 
account the heat treatment, duplicate, and the storage time (study V only) was applied in the 
sensory evaluation in studies III and V to yield the significance of differences between various 
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sensory attributes of vacuum-packaged hot-smoked fish products and sous vide meat foods 
treated by various heat processes with respect to their lethality to nonproteolytic C. botulinum 
spores.  
 
 
Table 6. Vacuum-packaged hot-smoked fish products used in study III and the effect of various 
thermal processes on the growth and toxin production from 106 nonproteolytic Clostridium botulinum 
spores in the fish products stored at 8ºC for 35 d. 
 
P85°C (min) using 
different z-values a 
 
 
Product ingredients, 
storage time (d) 
 
10.1-10.4°C 
 
7°C 
 
RH 
(%)b 
 
Time (d) to 
detection 
of C. 
botulinum  
 
 
pH 
 
NaCl 
(%[w:v]) 
 
Time 
to 
toxicity 
(d) 
        
Rainbow trout fillet 1.5 c 1.8 c 60 <7 6.4-6.9 <0.5 >35 
Rainbow trout fillet 25 119 25 <7 6.4-6.9 <0.5 >35 
Rainbow trout fillet 26 127 70 <35 6.4-6.9 <0.5 >35 
Rainbow trout filletd 34 189 75 >35 6.4-6.9 <0.5 >35 
Whole whitefish 1.5 c 1.8 c 50 <7 6.7-7.6 <0.5 35 
Whole whitefish 42 220 80 >35 6.7-7.6 <0.5 >35 
Whole whitefish 44 235 10 <7 6.7-7.6 <0.5 35 
Whole whitefish 62 386 80 >35 6.7-7.6 <0.5 >35 
        
a The z-values 10.1-10.4ºC were obtained in the present study, and 7ºC was according to ECFF (1996). 
b The mean relative humidity (approximation to the nearest 5%) measured during the most effective 
30-min period at the end of heat process. 
c Heat process currently employed in the Finnish smoked fish industry. 
d The products with no detectable C. botulinum or toxin during the entire storage period are written in 
bold text. 
   
Table 7. Sous vide products and the effect of various thermal processes on the growth and toxin production from 105.3 nonproteolytic Clostridium botulinum 
spores in the sous vide foods stored at 4 and 8ºC for 9 to 37 d. 
 
C. botulinum  
detected  
 
Time to 
toxicity (d)  
 
Product ingredients, storage time (d) 
 
P85ºC 
(min)a 
  4ºC 
 
 
8ºC 
 
Predicted log 
reduction in 
spore number 
by FMM 
 
pH 
 
NaCl 
(%[w:v]) 
  4ºC 
 
8ºC 
 
Predicted time to 
turbidity at 8ºC 
by PMP (d) 
 
Study 
           
Pork cubes, 41-21 15 b Yes Yes NEc 6.0-6.3 0.7 >21 21 <2.4d IV 
Pork cubes, 30-37 103 b Yes Yes 1.4 5.8-6.1 0.7 >37 >37 7 IV 
Beef cubes, 21-28 336 b Yes Yes >12.0 5.8-6.1 0.2 >28 >28 >90 IV 
Beef cubes, 14-21 126 b No Yes 1.6 5.6-6.1 0.7 >21 >21 9 IV 
Pork fillet, 10-17 7.1 b Yes Yes NE 5.8-6.0 2.0 >17 >17 <2.3d IV 
Beef roast, 30-37 13 b Yes Yes NE 5.7-6.1 1.6 >37 >37 <2.2d IV 
Beef roast, 9-16 3.7 b Yes Yes NE 5.6-5.8 1.9 >16 >16 <2.5d IV 
Ground beef, 21-28 <0.1 b Yes Yes NE 5.5-6.0 0.2 >21 21 <3.5d IV,V 
Beef liver cubes, 21-28 304 b Yes Yese >12.0 6.1-6.3 0.3 >28 >28 >90 IV 
Broiler fillets, marinade, 21-28 56 b Yese No 0.5 5.9-6.1 1.4 >28 >28 3 IV 
Rice, vegetables, pork, seafood, 21-28  69 b No Yes 2.2 5.8-6.0 1.9 >28 >28 13 IV 
Rice, water, milk, 21-28 ND b, f Yes Yes >12.0 6.1-6.7 1.1 >28 >28 >90 IV 
Beef, pork, water, vegetables, 21-28 1.7 b Yes Yes NE 4.8-5.1 1.3 >28 >28 <4.5d IV 
Beef, vegetables, water, 30-37 g 236  b No No 6.1 4.7-5.3 1.3 >37 >37 >90 IV 
Water, potatoes, beef, vegetables, 21-28 250 b Yes Yese >12.0 5.3-5.8 1.0 >28 >28 >90 IV 
Pork, vegetables, water, 21-28 80 b No No 3.8 4.9-5.3 1.0 >28 >28 43 IV 
Ground beef, 21 67 No Yes ND 6.0 0.2 >21 >21 ND V 
Pork cubes, 14 2 b Yes Yes ND 6.2 0.7 >14 14 ND V 
Pork cubes, 14  515 No No ND 6.2 0.7 >14 >14 ND V 
           
a Assuming a z-value of 7ºC. The P82.2ºC values originally determined in study IV were converted to P85ºC values by using the formula 10( T-Tref)/z, where T is the 
actual temperature and Tref is 85ºC. 
b Heat process employed in the Finnish sous vide industry. 
c NE, no effect; process temperature was below the model limits. 
d The initial number of organisms was outside the model limits. 
e Viable C. botulinum counts were detected with a low inoculum level of 102 spores/kg. 
f ND, not determined. 
g The products with no detectable C. botulinum or toxin during the entire storage period at any temperature are written in bold text. 
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5. RESULTS 
 
5.1 Applicability of biochemical test systems in identification of 
Clostridium botulinum (I) 
 
None of the three test systems was able to identify both group I and group II C. botulinum. 
Neither were they capable of distinguishing C. botulinum from their nontoxigenic 
counterparts. The API 20 A test alone identified most of the proteolytic C. botulinum strains 
(78%) and all the C. sporogenes strains correctly as C. botulinum/C. sporogenes. However, 
this test system misidentified all group II C. botulinum strains, most of them (68%) being 
identified as Clostridium perfringens. The Rapid ID 32 A and RapID ANA II misidentified all 
group I C. botulinum strains, whereas they both correctly identified the majority of group II 
C. botulinum strains (97 to 99%). However, they also falsely classified almost all 
nontoxigenic group II strains (97%) as C. botulinum. 
 
5.2 Multiplex PCR detection of Clostridium botulinum  (II) 
 
The multiplex PCR yielded amplification fragments of 782 bp for C. botulinum type A strains 
alone, 205 bp for type B alone, 389 bp for type E alone, and 543 bp for C. botulinum type F 
strains alone. Other bacterial strains included in the study did not yield a PCR product. The 
sensitivity of the multiplex PCR, when using DNA from pure C. botulinum cultures as 
template, was 10 cells for type B and 102 cells for types A, E, and F. When present in the 
multiplex PCR, >0.2, >1.0, and >2.0 µg/µl of minced meat inhibited the amplification of type 
A fragment, types E and F fragments, and type B fragment, respectively. Fish and faeces did 
not inhibit the PCR at the level of 10 µg/µl reaction mixture. The detection limit of the entire 
assay including the two-step enrichment procedure was lowest, 10-2 spore/g, for C. botulinum 
type A in minced beef and for type B in minced beef and fish. The highest detection limit was 
103 spores/g of faeces observed for type E. The optimal enrichment time varied from 1 to 5 d 
depending on the C. botulinum type and sample material, with only a 1-d incubation being 
required for the detection of C. botulinum type B in beef and type E in fish. Of the 72 
naturally contaminated food samples, C. botulinum type A was detected in two fish heads 
(2.8%), types B and E in two vegetable sausages (2.8%), and type B in a can of deer meat 
(1.4%). 
 
5.3 Heat resistance of nonproteolytic Clostridium botulinum type E 
spores in model fish media (III) 
 
Biphasic thermal destruction curves were observed when heating 106 spores of nonproteolytic 
C. botulinum type E in model media consisting of rainbow trout or whitefish at the 
temperature range of 75 to 93ºC, followed by incubation in the presence of lysozyme at 30ºC 
for 90 d. The D-values obtained for the heat-resistant spore fractions (Table 8) were 10-to-50-
fold longer than those obtained for the non-heat resistant spores. The spore heat resistance was 
greater in rainbow trout medium than in whitefish medium. The z-values obtained for the 
  36 
heat-resistant spore fractions were approximately 10ºC (Table 8). The total heating times 
required to destroy the entire inoculum of 106 nonproteolytic type E spores were 149 min at 
85ºC and 6.2 min at 93ºC for trout, and 55 min at 81ºC and 8.6ºC at 90ºC for whitefish. 
 
 
Table 8. D and z-values of heat-resistant fraction of nonproteolytic Clostridium botulinum type E 
spores heated in model fish media at 75 to 93ºC. 
 
Medium 
 
D-values (min) at 75 to 93ºC 
 
z-value 
  75 
 
81 
 
85 
 
90 
 
93 
 
(ºC) 
       
Rainbow trout 255 NDa 98 ND 4.2 10.4 
Whitefish ND 55 ND 7.1 ND 10.1 
       
 a ND, not determined. 
 
 
5.4 Safety evaluation and development of thermal processes 
employed in the REPFED industry (III-V) 
 
5.4.1 Vacuum-packaged hot-smoked fish products (III) 
 
The safety evaluation of the hot-smoking processes employed by five Finnish smoked fish 
companies revealed that the processes corresponded to heating at 85ºC for 6.1 min or less. In 
the inoculated pack study, a similar process of 1.5 min at 85ºC failed to eliminate 106 spores 
of nonproteolytic C. botulinum type E, and resulted in elevated viable counts in vacuum-
packaged hot-smoked rainbow trout and whitefish, and toxin production in whitefish stored at 
8ºC for 35 d. Moist heat treatments of 34 and 42 min at 85ºC, with RH>70%, were observed 
to control the growth and toxin production from 106 type E spores in smoked rainbow trout 
and whitefish, respectively, stored at 8ºC for 35 d (Tables 6 and 9). The high RH (>70%) in 
the smoking chamber was observed to significantly (p<0.01) enhance the thermal destruction 
of nonproteolytic type E C. botulinum spores; in whitefish processed at 85ºC for 44 min but in 
the presence of 10% RH, elevated viable C. botulinum counts and toxin production were 
observed within 35 d at 8ºC (Table 6).  
 
5.4.2 Sous vide products (IV, V) 
 
The safety evaluation of 16 sous vide products revealed that the processes employed by the 
Finnish sous vide industry corresponded to heating at 85ºC for <0.1-336 min. Only two of 
these processes with P85ºC values of 80 and 236 min were regarded as safe in the inoculated 
pack study. These processes controlled the growth and toxin formation from 105.3 spores of 
nonproteolytic C. botulinum type B in pork and beef-based mixed foods stored at 8ºC for 28 
and 37 d, respectively (Tables 7 and 9). All the other processes with P85ºC values of <0.1-336 
min allowed for the survival of C. botulinum spores and subsequent elevation of viable 
C. botulinum counts. Furthermore, following processing at 85ºC for 15 min or less, toxin 
formation was observed at 8ºC in pork cubes and ground beef within 14 and 21 d, respectively 
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(Table 7). In study V, an attempt to improve the heat processing of the high-risk pork cube 
and ground beef products revealed that a heat process with a P85ºC value of 515 min was 
sufficient to control botulinal growth and toxin formation in pork cubes stored at 8ºC for 14 d. 
With beef, the increased process of 67 min at 85ºC was sufficient at a storage temperature of 
4ºC, but allowed for elevated viable type B counts, although not toxin production in 21 d at 
8ºC. 
 
Table 9. Heat processes observed to control the growth and toxin formation from 105.3-106 spores of 
nonproteolytic Clostridium botulinum in REPFED products stored for 2-5 weeks at 8ºC.  
 
Product 
 
 
Safe storage time (d) 
 
P85ºCa 
 
Study 
    
Vacuum-packaged hot-smoked rainbow trout 35 34b III 
Vacuum-packaged hot-smoked whitefish 35 42 b III 
Sous vide beef, vegetables, water  37 236 IV 
Sous vide pork, vegetables, water 28 80 IV 
Sous vide pork cubes 14 515 V 
    
a Assuming a z-value of 10.1-10.4ºC (study III) for fish and 7ºC (ECFF, 1996) for sous vide foods. 
b Provided that the RH inside the smoking chamber was higher than 70%. 
 
 
5.4.3 Applicability of predictive microbiological models (IV) 
 
The thermal death model by FMM was inconsistent with the PCR results obtained in the 
inoculated pack study (Table 7). More than 12-D reductions were predicted for products 
showing viable C. botulinum counts at sell-by date and/or 1 week after. The lag time for 
growth model by FMM and time to turbidity model by PMP (Table 7) were also inconsistent 
with the PCR results. Fail-safe predictions were generated in the majority of the cases, but 
with a beef liver product a 90-d safe storage time was predicted, while viable C. botulinum 
counts were detected in several samples stored at 4 and 8ºC (Table 7). 
 
5.5 Sensory evaluation of REPFED products (III-V) 
 
All sensory attributes of the vacuum-packaged hot-smoked rainbow trout samples treated at 
85ºC for 42 min at >70% RH (study III) were significantly weaker than those of the samples 
processed for 0.3 min. However, all products were perceived to be optimally cooked. In 
whitefish products, only the juiciness was slightly decreased by processing at 85ºC for 42 min 
in the presence of >70% RH in comparison to the mild processing. All products were 
considered to be cooked to the correct degree. 
In reference to fresh products, the sensory quality of sous vide foods stored at 8ºC for 
various times remained acceptable for human consumption during the entire storage period 
(study IV). As for sous vide meat products, heat treatments at 85ºC for 67-515 min ensured 
equal or increased colour, flavour, aroma, juiciness, and tenderness when compared to heating 
at 85ºC for 2 min or less (study V). Moreover, the effective heat treatment resulted in a 
decreased greyness in the ground beef.  
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6. DISCUSSION 
 
6.1 Evaluation of biochemical test systems (I)  
 
The biochemical test systems, API 20 A, Rapid ID 32 A, and RapID ANA II were shown to 
be inappropriate for the identification of C. botulinum (study I). While the API 20 A system 
could only correctly identify the proteolytic C. botulinum strains, the Rapid ID 32 A and 
RapID ANA II systems misidentified all those strains but were accurate for the nonproteolytic 
C. botulinum. As group I and group II C. botulinum are phenotypically completely distinct 
(Smith and Sugiyama, 1988; Whitmer and Johnson, 1988) the result with API 20 A is not 
surprising since it only provides a single identification of ‘C. botulinum/C. sporogenes’, and 
thus does not differentiate between the organisms of group I and II. The capability of API 20 
A to identify C. difficile was greatly improved when the test strips were incubated for 48 h 
instead of 24 h (Gresser et al., 1984). In the present study, the extension of incubation time 
from 24 to 48 h improved the identification of some C. botulinum strains but impaired that of 
other strains, indicating that the enzymatic reactions by individual bacterial strains occur at 
different speeds. The Rapid ID 32 A and RapID ANA II test systems provide a possibility to 
identify both group I and II C. botulinum, but both of these tests failed to recognize the group 
I strains. This is in agreement with a previous report on the Rapid ID 32 A system that readily 
identified group II C. botulinum but failed with group I organisms (Brett, 1998). As reported 
with C. difficile, the presence of oxygen in the test environment may drastically affect the 
activity of some enzymes used in the identification with RapID ANA II (Peiffer and Cox, 
1993). In the present study the hydrolysis of proline, phenylalanine, and arginine by the group 
I organisms was reduced in RapID ANA II as compared to the prediction provided by the test. 
This might be due to the aerobic incubation of the RapID ANA II test strips as instructed by 
the manufacturer.  
None of the tests were able to distinguish C. botulinum from the nontoxigenic strains , 
which suggests that these strains are very similar to their toxigenic counterparts in terms of 
phenotypical characteristics. The genotypical relatedness between C. botulinum and the 
nontoxigenic strains has been shown (Lee and Riemann, 1970a, b; Nakamura et al., 1977).  
 
6.2 Development of multiplex PCR assay (II) 
 
The multiplex PCR assay developed in study II enabled sensitive and specific simultaneous 
detection of C. botulinum types A, B, E, and F in pure cultures as well as in food and faecal 
material. Four new primer pairs were designed in order to ensure optimal annealing at 60ºC. 
In the previously reported PCR protocols (Franciosa et al., 1994; Szabo et al., 1994; 
Sciacchitano and Hirshfield, 1996; Takeshi et al., 1996) the great variation between the 
melting temperatures of single primers would not allow multiplex reactions. The smallest size 
of the type B amplification fragment probably explains the sensitivity of the assay being 10-
fold better for type B than for the other types. Moreover, the amplification of the type B 
fragment was not as likely to be inhibited by the sample materials as was that of types A, E, 
and F (II Table 3). Since the multiplex PCR assay was developed, two years’ experience with 
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various types of sample materials has shown the amplification of the type A fragment to be 
more sensitive to inhibition than that of types B, E, and F. In study IV, as discussed in 6.4, it 
is probable that the greater amplification fragment size of C. botulinum types B and F as 
opposed to that of type E (Franciosa et al., 1994; Hielm et al., 1996) impaired the PCR 
detection of types B and F. Therefore, the multiplex PCR assay developed in the present work 
provides an appropriate tool for challenge tests employing a mixture of nonproteolytic 
C. botulinum types B, E, and F. 
The detection limit of the entire assay including two-step enrichment was best (10-2 
spores/g) for types A and B being detected in beef, and for types B and F detected in 
whitefish. However, the optimal enrichment times for type A in beef and type F in fish were 5 
d, whereas only 1-d enrichment was required for the detection of type B in beef and type E in 
whitefish (II Table 4). As C. botulinum type B seems to be naturally present in meats and 
particularly type E in fish (Tables 1 and 2), it is possible that the natural niches also support 
the germination and growth of these organisms better than those of the other C. botulinum 
strains, which results in improved PCR detection. Toxin formation observed only in the 
vacuum-packaged hot-smoked whitefish products but not in trout products in study III also 
agrees with the finding on whitefish supporting C. botulinum type E growth. In faeces the 
detection limit was relatively high, indicating the suppression of botulinal growth by the 
presence of other microflora. Using the multiplex PCR assay, the prevalence of C. botulinum 
types A, B, and E in various foods sold in Finland were shown to be 3-9%, which is of the 
order of the figures reported earlier (Tables 1 and 2). 
 
6.3 Heat resistance of nonproteolytic Clostridium botulinum type E 
spores in model fish media (III) 
 
The heat resistance of nonproteolytic C. botulinum type E spores was greater in rainbow trout 
medium than in whitefish medium (Table 8), probably due to greater fat and lysozyme content 
in trout. The D-values measured for the heat resistant spore fraction in trout were also greater 
than those in fish and seafood reported in the literature; a D75ºC-value of 255 min was 
observed in this study, while earlier D-values for type E at 73.9-76.7 ºC vary between 0.7 min 
in oyster homogenate (Chai and Liang, 1992) and 58.5 min in cod homogenate (Gaze and 
Brown, 1990) (Table 3). The difference may be explained by the effect of lysozyme, as 
lysozyme was not applied in the earlier studies. In phosphate buffer with lysozyme, a D75ºC-
value of 273 min was obtained for nonproteolytic type B spores (Peck et al., 1993).  
The reported D85ºC-values for types B and E in seafood without lysozyme supplement 
vary in the range of 0.2 (Cockey and Tatro, 1974) to 8.8 min (DePantoja, 1986), while those 
reported for type B in phosphate buffer in the presence of lysozyme are 48.5-100 min (Peck et 
al., 1993). The latter D-values are in agreement with the 98 min obtained for type E in trout in 
the present study. The present D93ºC-value of 4.2 min in trout medium is similar to those 
reported in phosphate buffer with lysozyme (Alderton et al., 1974; Peck et al., 1993), but also 
similar to those obtained in crabmeat in the absence of lysozyme (Peterson et al., 1997) (Table 
3). The D81ºC-value of 55 min measured in whitefish medium corresponds to those reported in 
phosphate buffer with (Scott and Bernard, 1985) and without lysozyme (Smelt, 1980; Scott 
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and Bernard, 1982) at the temperature range of 80 to 80.2ºC (Table 3). The only earlier study 
conducted with whitefish reported D-values at 80ºC of 1.6 to 4.3 min without lysozyme 
(Crisley et al., 1968). The present D90ºC-value in whitefish was 7.1 min, and is in the order of 
those reported for nonproteolytic type B spores heated in phosphate buffer (Smelt, 1980) and 
crabmeat (Peterson et al., 1997) without added lysozyme, but shorter than those measured for 
spores of types B and E in phosphate buffer in the presence of lysozyme (Peck et al., 1993) 
(Table 3). As lysozyme is probably not completely destroyed by heating (Garibaldi, 1986), it 
is possible that the great heat resistance observed in crabmeat (Peterson et al., 1997) is due to 
the activity of natural lysozyme or some other enzyme with a similar activity. 
The z-values of approximately 10ºC obtained in the two fish media are somewhat higher 
than those generally reported for the nonproteolytic C. botulinum (ECFF, 1996). However, 
similar or greater z-values of 9.4 to 14.5ºC have been measured for nonproteolytic C. 
botulinum type E in phosphate buffer (Smelt, 1980), crawfish (DePantoja, 1986), turkey slurry 
(Juneja et al., 1995), and in carrot homogenate (Gaze and Brown, 1990), and for type B in 
phosphate buffer (Smelt, 1980; Scott and Bernard, 1982), turkey slurry (Juneja and Eblen, 
1985), and in carrot homogenate (Gaze and Brown, 1990) (Table 3). The present z-values 
obtained in fish media were used in the inoculated pack study with fish products (III) to 
evaluate the processes with respect to the lethality to nonproteolytic C. botulinum type E 
spores. In comparison to the P85ºC values obtained with a z-value of 7ºC (ECFF, 1996), much 
shorter P85ºC values for the smoking processes were obtained with the present z-values (Table 
6). This demonstrates the great importance of determining the heat resistance parameters for 
each heating medium in order to estimate better the thermal inactivation, and survival, of 
nonproteolytic C. botulinum in various media. Using a false z-value in estimating the lethality 
of an unknown process may therefore lead to significant misjudgement of process lethality 
with respect to C. botulinum spores. 
 
6.4 Safety evaluation and development of thermal processes 
employed in the REPFED industry (III-V) 
 
The safety evaluation of hot-smoking (III) and sous vide processes (IV) revealed that the 
majority of the processes employed in the Finnish REPFED food industry represented 
considerable under-processing with respect to lethality to nonproteolytic C. botulinum. Only 
two sous vide products possessed complete protection against nonproteolytic C. botulinum 
type B at 8ºC. The P85ºC values of the safe heat processes were 80 and 236 min. All hot-
smoking processes (Table 6; III Table 1) and four sous vide products (Table 7; IV Table 4) 
were considered to possess a high risk related to botulinal growth and subsequent toxigenesis. 
The P85ºC values of the  high-risk processes were 15 min or shorter. Based on D85ºC-values 
determined for type E in fish media in the present study (III) and those for type B in meat 
(Scott and Bernard, 1985; Juneja and Eblen, 1995; Juneja et al., 1995; Juneja 1998), the high-
risk processes were estimated to cause a less than 103 reduction in the number of 
nonproteolytic C. botulinum spores. This estimation was supported by the results obtained in 
the inoculated pack studies (III-V).  
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The pH value had a marked effect on the probability of growth of C. botulinum in the 
sous vide products. As opposed to the safe sous vide foods with P85ºC values of 80 and 236 
min, pork cubes, beef cubes, and beef liver cubes processed with P85ºC values of 103-336 min, 
allowed botulinal growth at 4 and/or 8ºC. This is very probably explained by the difference 
between the pH measured in the products: the pH in the safe products varied in the range of 
4.9-5.8, partly inhibiting the growth of nonproteolytic C. botulinum (Segner et al., 1966), 
while in the pork, beef and liver cubes pH was 5.8-6.1. As confirmed by others (Lund et al., 
1985, 1990; McClure et al., 1994; Graham et al., 1996a, b; Graham et al., 1997), minor 
changes in the pH of a growth medium may influence the probability of growth and toxin 
formation by nonproteolytic C. botulinum. The pH and buffer capacity in different types of 
foods and raw materials varies greatly, and thus may even vary inside a single package of a 
ready-to-eat meal. In the REPFED food industry where a number of ready-to-eat meals are 
produced with a variety of ingredients, uncontrolled pH variations inside food packages may 
lead to the growth of pathogenic micro-organisms. 
Due to the evident safety hazard presented by nonproteolytic C. botulinum in the 
REPFED products manufactured in Finland, an effort to improve product safety identified 
heat treatments providing protection against 106 nonproteolytic spores in vacuum-packaged 
hot-smoked rainbow trout and whitefish stored at 8ºC for 35 d (III) (Tables 6 and 9) and in 
sous vide processed pork cubes and ground beef stored at 4 and /or 8ºC for 14-28 d (V) 
(Tables 7 and 9). In general, high-moisture (RH >70%) heat treatments equal to processing at 
85ºC for 34 and 42 min were required for rainbow trout and whitefish products, respectively. 
A high RH of >70% inside the smoking chamber was an absolute prerequisite for the product 
safety; a 44-min heat process at 85ºC but with an RH of 10% resulted in toxigenesis in 
whitefish stored at 8ºC. An enhancing effect of moist heat on the thermal destruction of 
C. botulinum spores has been described (Alderman et al., 1972; Pace et al., 1972), and it is 
apparently due to an increased aw on the fish surface. As study III indicated, the Finnish 
smoked fish industry has the technology required to control RH in the smoking chambers 
during processes. The implementation of hot-smoking processes with a high RH described in 
the present work is therefore strongly recommended in order to improve the safety of vacuum-
packaged hot-smoked fish products. However, as the intrinsic control factors in hot-smoked 
fish products are limited, strict adherence to refrigerated storage must be stressed. 
The moist heat treatments required to control nonproteolytic C. botulinum type E in fish 
were greater than the heat treatment of 18.1-23.3 min at 85ºC, reported to control the growth 
from 106 spores of nonproteolytic types B, E, and F in meat medium supplemented with 
lysozyme and stored for 48-64 d at 8ºC (Graham et al., 1996a; Fernández and Peck, 1999) 
(Table 4). In the present study, a 15-min process at 85ºC resulted in toxin formation in pork 
cubes stored for 21 d at 8ºC. Based on earlier studies on spore heat resistance with or without 
lysozyme (Smelt, 1980; Scott and Bernard, 1982, 1985; Peck et al., 1993; Juneja et al., 1995; 
Juneja, 1998), nonproteolytic type B spores seem to be more heat resistant than type E spores 
(Table 3). Therefore, as the observed heat resistance of type E spores in the fish (III) was 
much greater than that reported for type B spores in meat, it may be assumed that rainbow 
trout and whitefish provided protection for the type E spores, increasing their heat resistance. 
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Fat and protein are known to protect C. botulinum spores from heat (Lücke, 1985); this is 
particularly relevant for rainbow trout in which the fat content may be up to 20%. 
As opposed to the relatively short heat treatments required for the fish products, a 515-
min process at 85ºC, regardless of the RH, was sufficient  to control nonproteolytic 
C. botulinum type B in the sous vide pork cube product. In sous vide ground beef, heating at 
85ºC for 67 min combined with a storage temperature of 4ºC was sufficient, but this combined 
with storage at 8ºC allowed a slight elevation of viable C. botulinum counts, but not 
toxigenesis. In reference to the earlier in vitro studies with meat medium, it is evident that the 
meat products studied in IV and V increased the heat resistance of the nonproteolytic type B 
spores: while heating at 85ºC for 18.1 min controlled nonproteolytic type B in meat medium 
with lysozyme at 8ºC for 64 d (Graham et al., 1996a; Fernández and Peck, 1999), a similar 
process at 85ºC for 15 min resulted in toxin formation in pork cubes within 21 d at 8ºC. Based 
on these findings, the importance of challenge testing with food products over in vitro 
experiments and predictive models was clearly demonstrated. This was supported by the 
observation that the predictions for the spore reduction, lag time to growth, and time to 
toxigenesis, generated by the predictive models FMF and PMP were inconsistent with the data 
obtained in the inoculated pack study (IV).  
The heat treatments required to control C. botulinum in fish were generally shorter than 
those for sous vide products. Apart from the significant effect of RH enhancing the spore 
thermal destruction in fish, the obvious difference in the heat resistance between 
nonproteolytic type B and E spores (Table 3) has probably contributed to the process 
requirements. Furthermore, the sous vide products were packaged prior to processing, while 
the fish were processed unpackaged. Therefore, it is possible that the polyethylene film 
covering the sous vide foods retarded the heat penetration into the products. In order to 
simulate natural contamination of the products, the spore inoculum was mixed into the sous 
vide products with a relatively small particle size, while that in the fish was sprayed on the 
fish surface, more readily exposed to heat and moisture. A comparison between the two fish 
products also supported this theory: although  the heat resistance of type E spores in trout 
medium was greater than in whitefish medium, all trout fillets remained nontoxic during the 
entire storage at 8ºC, while whole whitefish allowed toxin formation at the same temperature. 
The rate of heat, moisture, and smoke transfer on the fillets was apparently greater than that in 
the whole fish carrying the spore inoculum inside the abdominal cavity. Additionally, 
evidence of whitefish supporting the growth of nonproteolytic C. botulinum type E is also 
reported in the study II. 
The z-values of 10.1-10.4ºC obtained in study III were used to determine the P85ºC 
values of the fish hot-smoking processes required to control C. botulinum growth. Based on 
these values, relatively short heat treatments of 34-42 min at 85ºC, in comparison to the 80-
515 min at 85ºC required with sous vide foods, were required to control the botulinum toxin 
formation in the fish products. By using the recommended z-value of 7ºC (ECFF, 1996), the 
P85ºC values of the safe heat treatments for trout and whitefish were 189 and 220 min, 
respectively (Table 6). Such processes would be of the order of those observed to ensure the 
safety of sous vide foods, and would probably deteriorate the sensory quality of fish. As the z-
values of approximately 10ºC were experimentally observed for nonproteolytic C. botulinum 
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type E spores in fish (III), these values and the corresponding P85ºC values are probably closer 
to reality than the recommended values (ECFF, 1996) obtained for nonproteolytic type B 
spores in vitro. The short P85ºC-values of the safe smoking processes are explained by the 
effect of RH that is not taken into account when estimating pasteurization values. 
The sensory quality of all sous vide foods remained acceptable during the entire storage 
period of 9-37 d at 8ºC. Moreover, positively from the sensory aspect, the intensified heat 
processing of sous vide beef and pork products enhanced the sensory attributes of these food 
products. With fish products the effect of intensified processing was less favourable. All 
safely processed trout and whitefish products were perceived to be cooked to the correct 
degree. Naturally the prolonged heating of unpackaged fish at an increased temperature will 
result in a decrease in juiciness, while in the sous vide foods, packaged prior to processing, 
the juiciness was actually enhanced by the intensified heat treatments. Apart from a loss of 
juiciness, the safely processed whitefish were considered to be similar to the mildly processed 
whitefish products (III, Fig. 5). The sensory quality of the rainbow trout seemed to be 
somewhat more sensitive to the intensified heating combined with a high RH (III, Fig. 4). 
However, the use of the intensified high-RH processes in the fish industry, that currently 
employs too mild processes as determined in study III, is essential to improve the safety of 
vacuum-packaged hot-smoked fish products. Alternative control strategies such as restricted 
product shelf lives should otherwise be established to ensure the safety of vacuum-packaged 
hot-smoked fish products.  
The PCR method combined with two-step enrichment (Franciosa et al., 1994; Hielm et 
al., 1996; Sciacchitano and Hirshfield, 1996) employed in the detection of viable 
C. botulinum counts in studies III-V, is very sensitive but does not differentiate between 
spores and vegetative cells of C. botulinum. To obtain more data on the growth behaviour of 
C. botulinum in the products, sampling at a shorter interval throughout  the entire storage 
period would be desirable. However, conducting extensive safety evaluations, such as in study 
IV, with the PCR method used (Franciosa et al., 1994; Hielm et al., 1996) is very laborious  
and expensive, as a single serotype out of the three tested can be detected at a time. Moreover, 
as demonstrated in Tables 2 and 3 of study IV, the probability of detecting C. botulinum type 
E in the samples seemed to be greater than that for types B and F. This is probably due to 
inhibition of PCR, since the heat resistance of nonproteolytic C. botulinum type B and F 
spores seems to be greater than that of type E (Table 3). The use of the novel multiplex PCR 
method described in study II would therefore markedly facilitate safety evaluations. 
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7. CONCLUSIONS 
 
1. None of the three commercially available biochemical test systems (API 20 
A, Rapid ID 32 A, and RapID ANA II) were able to identify both group I 
and group II C. botulinum, neither were they capable of distinguishing group 
I and II C. botulinum from their nontoxigenic counterparts. Thus, these test 
systems are not suitable for the identification of C. botulinum. 
 
2. The multiplex PCR assay developed provides a sensitive and specific tool 
for the simultaneous detection of C. botulinum types A, B, E, and F in pure 
cultures, as well as in food and faecal material. The method improves the 
diagnostics of the C. botulinum strains pathogenic to humans. 
 
3. Biphasic thermal destruction curves were observed when recovering the 
heated spores in the presence of lysozyme, yielding greater D-values for the 
heat resistant spores permeable to lysozyme than for the non-heat-resistant 
spores. The z-values obtained for nonproteolytic C. botulinum type E in the 
fish media were approximately 10ºC. The heat resistance of nonproteolytic 
C. botulinum type E spores was affected by the heating medium, being 
greater in rainbow trout than in whitefish medium. This indicates that 
rainbow trout provides more protection against heat for C. botulinum spores 
than whitefish.  
 
4. All fish hot-smoking processes and most of the sous vide processes 
evaluated, employed by the Finnish food industry, represented considerable 
under-processing with respect to elimination of nonproteolytic C. botulinum 
spores. Heat treatments equal to processing at 85ºC for 15 min or less were 
shown to possess a high risk, and resulted in growth and toxin formation 
from 105.3-106 nonproteolytic spores in sous vide foods and in vacuum-
packaged hot-smoked whitefish and in the inoculated pack studies. 
 
5. Thermal processes controlling the growth and toxin production from 105.3-
106 spores of nonproteolytic Clostridium botulinum in vacuum-packaged 
hot-smoked fish products and sous vide products stored at 4 and 8ºC were 
identified. Moist heat treatments at 85ºC for 34 and 42 min, combined with 
RH>70%, controlled the growth and toxin formation from nonproteolytic 
type E spores in rainbow trout and whitefish, respectively, for 35 d at 8ºC. 
Heating at 85ºC for 515 and 67 min controlled the toxigenesis from 
nonproteolytic type B spores in sous vide pork cubes and ground beef, 
respectively, at 8ºC. However, elevated viable C. botulinum counts were 
detected in ground beef. The use of the described processes in combination 
with proper refrigeration is strongly recommended in order to improve the 
safety of REPFED products. 
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6. The sensory quality of the sous vide foods remained acceptable during the 
entire storage period at 8ºC. Intensified heating with processes shown to 
ensure the product safety with respect to nonproteolytic C. botulinum 
enhanced the sensory attributes of sous vide meat products, did not 
markedly affect those of hot-smoked whitefish, and slightly decreased those 
of hot-smoked rainbow trout products. 
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